[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fnnSqkrzRbnCoMG9j9Vpvgxy_1UzheNSmYDJId03x3pc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":85,"rows":92},"Hospital for Special Surgery, New York",[4],223,false,54,10,44842,28,133,[14,17,20,22,25,28,31,33],{"name":15,"count":16},"Opioid Use",13,{"name":18,"count":19},"Pain",9,{"name":21,"count":19},"Knee Osteoarthritis",{"name":23,"count":24},"Pain, Postoperative",8,{"name":26,"count":27},"Osteoarthritis",7,{"name":29,"count":30},"Total Knee Arthroplasty",6,{"name":32,"count":30},"Postoperative Pain",{"name":34,"count":35},"Antiphospholipid Syndrome",5,[37,42,47,52,57,62,67,71,76,80],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT04082533","Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)","2026-05","Hydrocortisone",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT03844061","Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis","2026-06-30","Belimumab",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT02868567","Use of Dalfampridine in Primary Lateral Sclerosis","2026-07","dalfampridine",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT06306157","Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome","2026-08","Low dose naltrexone",{"nctId":58,"briefTitle":59,"date":60,"intervention":61},"NCT05444751","GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries","2026-09","General anesthetic",{"nctId":63,"briefTitle":64,"date":65,"intervention":66},"NCT05675527","PRP for Glenohumeral Osteoarthritis","2026-09-01","Low-dose PRP",{"nctId":68,"briefTitle":69,"date":65,"intervention":70},"NCT04467983","Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone","Denosumab",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT03968822","Intralipid® 20% for Reversal of Local Anesthetics","2026-10","Lidocaine 2%",{"nctId":77,"briefTitle":78,"date":74,"intervention":79},"NCT04057833","E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults","E-CEL UVEC",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT05058287","Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression","2026-12-31","Depo-Medrol 40Mg\u002FMl Suspension for",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,130,155,173,191,209,227,250,268,295,318,343,371,389,417,435,484,506,545,569,587,613,655,684,702,723,746,778,807,910,976,1015,1037,1059,1089,1111,1133,1168,1195,1223,1248,1272,1299,1317,1341,1366,1384,1410,1428,1451,1469,1495,1513,1531,1549,1574,1592,1610,1628,1653,1671,1695,1721,1746,1771,1797,1821,1839,1857,1875,1893,1918,1936,1961,1979,1997,2015,2041,2059,2077,2095,2113,2138,2163,2181,2199,2221,2245,2269,2295,2313,2331,2349,2367,2385,2412,2430,2448,2473,2499,2524,2542,2566,2584,2608,2632,2655,2686,2704,2745,2782,2809,2834,2862,2880,2898,2916,2934,2952,2976,2994,3018,3041,3059,3082,3106,3129],{"intervention":94,"totalTrials":95,"cells":96},"Abaloparatide",2,{"EARLY_PHASE1":97,"PHASE1":100,"PHASE2":102,"PHASE3":116,"PHASE4":118,"NA":128},{"trials":98,"activeCount":99},[],0,{"trials":101,"activeCount":99},[],{"trials":103,"activeCount":115,"soonestReadout":109},[104],{"nctId":105,"briefTitle":106,"status":107,"phases":108,"primaryCompletion":109,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":114},"NCT03841058","Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery","ACTIVE_NOT_RECRUITING",[88],"2027-02","2019-08-14",96,[113],"Spinal Fusion",[94],1,{"trials":117,"activeCount":99},[],{"trials":119,"activeCount":115,"soonestReadout":65},[120],{"nctId":68,"briefTitle":69,"status":107,"phases":121,"primaryCompletion":65,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},[90],"2026-12-01","2021-02-01",70,[126],"Osteoporosis, Postmenopausal",[70,94],{"trials":129,"activeCount":99},[],{"intervention":75,"totalTrials":115,"cells":131},{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":136,"PHASE3":138,"PHASE4":140,"NA":153},{"trials":133,"activeCount":99},[],{"trials":135,"activeCount":99},[],{"trials":137,"activeCount":99},[],{"trials":139,"activeCount":99},[],{"trials":141,"activeCount":115,"soonestReadout":74},[142],{"nctId":72,"briefTitle":73,"status":107,"phases":143,"primaryCompletion":74,"completion":74,"start":144,"enrollment":145,"conditions":146,"interventions":148},[90],"2019-07-26",18,[147],"Anesthesia, Local",[75,149,150,151,152],"Lidocaine 1%","Bupivacaine 0.25%","Bupivacaine 0.5%","Intralipid, 20% Intravenous",{"trials":154,"activeCount":99},[],{"intervention":149,"totalTrials":115,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":171},{"trials":158,"activeCount":99},[],{"trials":160,"activeCount":99},[],{"trials":162,"activeCount":99},[],{"trials":164,"activeCount":99},[],{"trials":166,"activeCount":115,"soonestReadout":74},[167],{"nctId":72,"briefTitle":73,"status":107,"phases":168,"primaryCompletion":74,"completion":74,"start":144,"enrollment":145,"conditions":169,"interventions":170},[90],[147],[75,149,150,151,152],{"trials":172,"activeCount":99},[],{"intervention":150,"totalTrials":115,"cells":174},{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":189},{"trials":176,"activeCount":99},[],{"trials":178,"activeCount":99},[],{"trials":180,"activeCount":99},[],{"trials":182,"activeCount":99},[],{"trials":184,"activeCount":115,"soonestReadout":74},[185],{"nctId":72,"briefTitle":73,"status":107,"phases":186,"primaryCompletion":74,"completion":74,"start":144,"enrollment":145,"conditions":187,"interventions":188},[90],[147],[75,149,150,151,152],{"trials":190,"activeCount":99},[],{"intervention":151,"totalTrials":115,"cells":192},{"EARLY_PHASE1":193,"PHASE1":195,"PHASE2":197,"PHASE3":199,"PHASE4":201,"NA":207},{"trials":194,"activeCount":99},[],{"trials":196,"activeCount":99},[],{"trials":198,"activeCount":99},[],{"trials":200,"activeCount":99},[],{"trials":202,"activeCount":115,"soonestReadout":74},[203],{"nctId":72,"briefTitle":73,"status":107,"phases":204,"primaryCompletion":74,"completion":74,"start":144,"enrollment":145,"conditions":205,"interventions":206},[90],[147],[75,149,150,151,152],{"trials":208,"activeCount":99},[],{"intervention":152,"totalTrials":115,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":225},{"trials":212,"activeCount":99},[],{"trials":214,"activeCount":99},[],{"trials":216,"activeCount":99},[],{"trials":218,"activeCount":99},[],{"trials":220,"activeCount":115,"soonestReadout":74},[221],{"nctId":72,"briefTitle":73,"status":107,"phases":222,"primaryCompletion":74,"completion":74,"start":144,"enrollment":145,"conditions":223,"interventions":224},[90],[147],[75,149,150,151,152],{"trials":226,"activeCount":99},[],{"intervention":66,"totalTrials":115,"cells":228},{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":237,"NA":248},{"trials":230,"activeCount":99},[],{"trials":232,"activeCount":99},[],{"trials":234,"activeCount":99},[],{"trials":236,"activeCount":99},[],{"trials":238,"activeCount":115,"soonestReadout":65},[239],{"nctId":63,"briefTitle":64,"status":240,"phases":241,"primaryCompletion":65,"completion":65,"start":242,"enrollment":243,"conditions":244,"interventions":246},"RECRUITING",[90],"2023-05-02",135,[245],"Shoulder Osteoarthritis",[66,247],"High-dose PRP",{"trials":249,"activeCount":99},[],{"intervention":247,"totalTrials":115,"cells":251},{"EARLY_PHASE1":252,"PHASE1":254,"PHASE2":256,"PHASE3":258,"PHASE4":260,"NA":266},{"trials":253,"activeCount":99},[],{"trials":255,"activeCount":99},[],{"trials":257,"activeCount":99},[],{"trials":259,"activeCount":99},[],{"trials":261,"activeCount":115,"soonestReadout":65},[262],{"nctId":63,"briefTitle":64,"status":240,"phases":263,"primaryCompletion":65,"completion":65,"start":242,"enrollment":243,"conditions":264,"interventions":265},[90],[245],[66,247],{"trials":267,"activeCount":99},[],{"intervention":56,"totalTrials":115,"cells":269},{"EARLY_PHASE1":270,"PHASE1":272,"PHASE2":274,"PHASE3":276,"PHASE4":278,"NA":293},{"trials":271,"activeCount":99},[],{"trials":273,"activeCount":99},[],{"trials":275,"activeCount":99},[],{"trials":277,"activeCount":99},[],{"trials":279,"activeCount":115,"soonestReadout":55},[280],{"nctId":53,"briefTitle":54,"status":281,"phases":282,"primaryCompletion":55,"completion":283,"start":284,"enrollment":285,"conditions":286,"interventions":292},"ENROLLING_BY_INVITATION",[90],"2026-11","2024-01-02",40,[287,288,289,290,291],"Complex Regional Pain Syndrome","Chronic Pain","Causalgia","Complex Regional Pain Syndrome Type I","Complex Regional Pain Syndrome Type II",[56],{"trials":294,"activeCount":99},[],{"intervention":296,"totalTrials":115,"cells":297},"Dextrose 5% in water",{"EARLY_PHASE1":298,"PHASE1":300,"PHASE2":302,"PHASE3":304,"PHASE4":306,"NA":316},{"trials":299,"activeCount":99},[],{"trials":301,"activeCount":99},[],{"trials":303,"activeCount":99},[],{"trials":305,"activeCount":99},[],{"trials":307,"activeCount":115,"soonestReadout":40},[308],{"nctId":38,"briefTitle":39,"status":107,"phases":309,"primaryCompletion":40,"completion":40,"start":310,"enrollment":311,"conditions":312,"interventions":315},[90],"2019-07-24",132,[18,313,314],"Arthrofibrosis","Osteoarthritis, Knee",[41,296],{"trials":317,"activeCount":99},[],{"intervention":319,"totalTrials":115,"cells":320},"Risedronate Oral",{"EARLY_PHASE1":321,"PHASE1":323,"PHASE2":325,"PHASE3":327,"PHASE4":329,"NA":341},{"trials":322,"activeCount":99},[],{"trials":324,"activeCount":99},[],{"trials":326,"activeCount":99},[],{"trials":328,"activeCount":99},[],{"trials":330,"activeCount":115,"soonestReadout":335},[331],{"nctId":332,"briefTitle":333,"status":240,"phases":334,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":340},"NCT04152551","Effects of Bisphosphonates on OI-Related Hearing Loss",[90],"2027-01","2019-11-02",100,[339],"Osteogenesis Imperfecta",[319],{"trials":342,"activeCount":99},[],{"intervention":344,"totalTrials":115,"cells":345},"Concentrated Bone Marrow Aspirate",{"EARLY_PHASE1":346,"PHASE1":348,"PHASE2":350,"PHASE3":352,"PHASE4":354,"NA":369},{"trials":347,"activeCount":99},[],{"trials":349,"activeCount":99},[],{"trials":351,"activeCount":99},[],{"trials":353,"activeCount":99},[],{"trials":355,"activeCount":115,"soonestReadout":360},[356],{"nctId":357,"briefTitle":358,"status":240,"phases":359,"primaryCompletion":360,"completion":361,"start":362,"enrollment":285,"conditions":363,"interventions":368},"NCT06311513","Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction",[90],"2027-12","2028-12","2024-01-22",[364,365,366,367],"Anterior Cruciate Ligament Injuries","Post-Traumatic Osteoarthritis of Knee","Bone Marrow Aspirate Concentrate","ACL Injury",[344],{"trials":370,"activeCount":99},[],{"intervention":70,"totalTrials":115,"cells":372},{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":381,"NA":387},{"trials":374,"activeCount":99},[],{"trials":376,"activeCount":99},[],{"trials":378,"activeCount":99},[],{"trials":380,"activeCount":99},[],{"trials":382,"activeCount":115,"soonestReadout":65},[383],{"nctId":68,"briefTitle":69,"status":107,"phases":384,"primaryCompletion":65,"completion":122,"start":123,"enrollment":124,"conditions":385,"interventions":386},[90],[126],[70,94],{"trials":388,"activeCount":99},[],{"intervention":390,"totalTrials":115,"cells":391},"Bupivacaine, Dexamethasone in Adductor Canal Block",{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":400,"NA":415},{"trials":393,"activeCount":99},[],{"trials":395,"activeCount":99},[],{"trials":397,"activeCount":99},[],{"trials":399,"activeCount":99},[],{"trials":401,"activeCount":115,"soonestReadout":406},[402],{"nctId":403,"briefTitle":404,"status":240,"phases":405,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":410,"interventions":413},"NCT06590402","Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees",[90],"2027-06","2028-01","2025-06-06",60,[411,412],"Anterior Cruciate Ligament Reconstruction","Medial Patellofemoral Ligament Reconstruction",[390,414],"Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block",{"trials":416,"activeCount":99},[],{"intervention":414,"totalTrials":115,"cells":418},{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":425,"PHASE4":427,"NA":433},{"trials":420,"activeCount":99},[],{"trials":422,"activeCount":99},[],{"trials":424,"activeCount":99},[],{"trials":426,"activeCount":99},[],{"trials":428,"activeCount":115,"soonestReadout":406},[429],{"nctId":403,"briefTitle":404,"status":240,"phases":430,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":431,"interventions":432},[90],[411,412],[390,414],{"trials":434,"activeCount":99},[],{"intervention":41,"totalTrials":436,"cells":437},4,{"EARLY_PHASE1":438,"PHASE1":440,"PHASE2":442,"PHASE3":444,"PHASE4":446,"NA":472},{"trials":439,"activeCount":99},[],{"trials":441,"activeCount":99},[],{"trials":443,"activeCount":99},[],{"trials":445,"activeCount":99},[],{"trials":447,"activeCount":115,"soonestReadout":40},[448,461,468],{"nctId":449,"briefTitle":450,"status":451,"phases":452,"primaryCompletion":453,"completion":454,"start":455,"enrollment":456,"conditions":457,"interventions":459},"NCT01399268","Steroids in Bilateral Total Knee Replacement","COMPLETED",[90],"2010-08","2011-02","2009-02",30,[458],"Postoperative Inflammatory Response",[41,460],"Saline",{"nctId":462,"briefTitle":463,"status":451,"phases":464,"primaryCompletion":465,"completion":465,"start":454,"enrollment":409,"conditions":466,"interventions":467},"NCT01815918","Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty",[90],"2012-04",[29],[41],{"nctId":38,"briefTitle":39,"status":107,"phases":469,"primaryCompletion":40,"completion":40,"start":310,"enrollment":311,"conditions":470,"interventions":471},[90],[18,313,314],[41,296],{"trials":473,"activeCount":99},[474],{"nctId":475,"briefTitle":476,"status":451,"phases":477,"primaryCompletion":478,"completion":478,"start":479,"enrollment":285,"conditions":480,"interventions":482},"NCT01782859","Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery",[91],"2014-01","2012-10",[481],"Total Hip Replacement",[483,41],"Prednisone",{"intervention":84,"totalTrials":115,"cells":485},{"EARLY_PHASE1":486,"PHASE1":488,"PHASE2":490,"PHASE3":492,"PHASE4":502,"NA":504},{"trials":487,"activeCount":99},[],{"trials":489,"activeCount":99},[],{"trials":491,"activeCount":99},[],{"trials":493,"activeCount":115,"soonestReadout":83},[494],{"nctId":81,"briefTitle":82,"status":240,"phases":495,"primaryCompletion":83,"completion":83,"start":496,"enrollment":497,"conditions":498,"interventions":501},[89],"2021-11-05",150,[15,499,23,500],"Lumbar Spinal Stenosis","Pain, Back",[84],{"trials":503,"activeCount":99},[],{"trials":505,"activeCount":99},[],{"intervention":507,"totalTrials":115,"cells":508},"Suzetrigine",{"EARLY_PHASE1":509,"PHASE1":511,"PHASE2":513,"PHASE3":515,"PHASE4":541,"NA":543},{"trials":510,"activeCount":99},[],{"trials":512,"activeCount":99},[],{"trials":514,"activeCount":99},[],{"trials":516,"activeCount":115,"soonestReadout":521},[517],{"nctId":518,"briefTitle":519,"status":240,"phases":520,"primaryCompletion":521,"completion":522,"start":523,"enrollment":524,"conditions":525,"interventions":540},"NCT07226700","Suzetrigine in Total Hip Arthroplasty",[89],"2027-11-01","2028-11-01","2025-11-03",210,[526,527,481,528,529,530,507,531,18,532,533,534,535,536,537,538,539],"Total Hip Arthroplasty (THA)","Total Hip Arthroplasty \\(THA\\)","Total Hip Replacement Surgery","Total Hip Replacements","Total Hip Replacement Arthroplasty","Pain Management","Nav 1.8","JOURNAVX","Opioid Cessation","Opioid Consumption, Postoperative","Multimodal Analgesia","Randomized Controlled Trial","Randomized Controlled Study","Randomized Controlled Trials",[507],{"trials":542,"activeCount":99},[],{"trials":544,"activeCount":99},[],{"intervention":61,"totalTrials":115,"cells":546},{"EARLY_PHASE1":547,"PHASE1":549,"PHASE2":551,"PHASE3":553,"PHASE4":565,"NA":567},{"trials":548,"activeCount":99},[],{"trials":550,"activeCount":99},[],{"trials":552,"activeCount":99},[],{"trials":554,"activeCount":115,"soonestReadout":60},[555],{"nctId":58,"briefTitle":59,"status":281,"phases":556,"primaryCompletion":60,"completion":60,"start":557,"enrollment":558,"conditions":559,"interventions":563},[89],"2022-03-22",142,[560,561,562],"Lumbar Disc Herniation","Lumbar Disc Disease","Lumbar Radiculopathy",[61,564],"SA + ESP",{"trials":566,"activeCount":99},[],{"trials":568,"activeCount":99},[],{"intervention":564,"totalTrials":115,"cells":570},{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":583,"NA":585},{"trials":572,"activeCount":99},[],{"trials":574,"activeCount":99},[],{"trials":576,"activeCount":99},[],{"trials":578,"activeCount":115,"soonestReadout":60},[579],{"nctId":58,"briefTitle":59,"status":281,"phases":580,"primaryCompletion":60,"completion":60,"start":557,"enrollment":558,"conditions":581,"interventions":582},[89],[560,561,562],[61,564],{"trials":584,"activeCount":99},[],{"trials":586,"activeCount":99},[],{"intervention":588,"totalTrials":115,"cells":589},"Tranexamic Acid 100 MG\u002FML",{"EARLY_PHASE1":590,"PHASE1":592,"PHASE2":594,"PHASE3":596,"PHASE4":609,"NA":611},{"trials":591,"activeCount":99},[],{"trials":593,"activeCount":99},[],{"trials":595,"activeCount":99},[],{"trials":597,"activeCount":115,"soonestReadout":602},[598],{"nctId":599,"briefTitle":600,"status":240,"phases":601,"primaryCompletion":602,"completion":602,"start":603,"enrollment":337,"conditions":604,"interventions":608},"NCT03553186","Tranexamic Acid in Adult Spinal Deformity Surgery",[89],"2027-03","2018-07-11",[605,606,607],"Spinal Deformity","Degenerative Lumbar Spinal Stenosis","Blood Loss, Surgical",[588],{"trials":610,"activeCount":99},[],{"trials":612,"activeCount":99},[],{"intervention":614,"totalTrials":615,"cells":616},"Rituximab",3,{"EARLY_PHASE1":617,"PHASE1":619,"PHASE2":621,"PHASE3":639,"PHASE4":641,"NA":653},{"trials":618,"activeCount":99},[],{"trials":620,"activeCount":99},[],{"trials":622,"activeCount":115,"soonestReadout":45},[623,632],{"nctId":624,"briefTitle":625,"status":451,"phases":626,"primaryCompletion":627,"completion":627,"start":628,"enrollment":629,"conditions":630,"interventions":631},"NCT00537290","A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome",[88],"2013-01","2007-09",19,[34],[614],{"nctId":43,"briefTitle":44,"status":240,"phases":633,"primaryCompletion":45,"completion":45,"start":634,"enrollment":456,"conditions":635,"interventions":637},[88],"2019-07-29",[636],"Systemic Sclerosis",[46,614,638],"MMF",{"trials":640,"activeCount":99},[],{"trials":642,"activeCount":99},[643],{"nctId":644,"briefTitle":645,"status":646,"phases":647,"primaryCompletion":648,"completion":648,"start":649,"enrollment":615,"conditions":650,"interventions":652},"NCT02626845","Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis","TERMINATED",[90],"2017-07","2015-12",[651],"Granulomatosis With Polyangiitis (Wegener's Granulomatosis)",[614],{"trials":654,"activeCount":99},[],{"intervention":46,"totalTrials":95,"cells":656},{"EARLY_PHASE1":657,"PHASE1":659,"PHASE2":661,"PHASE3":678,"PHASE4":680,"NA":682},{"trials":658,"activeCount":99},[],{"trials":660,"activeCount":99},[],{"trials":662,"activeCount":115,"soonestReadout":45},[663,674],{"nctId":664,"briefTitle":665,"status":451,"phases":666,"primaryCompletion":667,"completion":668,"start":669,"enrollment":670,"conditions":671,"interventions":672},"NCT01670565","Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis",[88],"2015-11","2016-02","2012-08",20,[636],[46,673],"Mycophenolate Mofetil",{"nctId":43,"briefTitle":44,"status":240,"phases":675,"primaryCompletion":45,"completion":45,"start":634,"enrollment":456,"conditions":676,"interventions":677},[88],[636],[46,614,638],{"trials":679,"activeCount":99},[],{"trials":681,"activeCount":99},[],{"trials":683,"activeCount":99},[],{"intervention":638,"totalTrials":115,"cells":685},{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":696,"PHASE4":698,"NA":700},{"trials":687,"activeCount":99},[],{"trials":689,"activeCount":99},[],{"trials":691,"activeCount":115,"soonestReadout":45},[692],{"nctId":43,"briefTitle":44,"status":240,"phases":693,"primaryCompletion":45,"completion":45,"start":634,"enrollment":456,"conditions":694,"interventions":695},[88],[636],[46,614,638],{"trials":697,"activeCount":99},[],{"trials":699,"activeCount":99},[],{"trials":701,"activeCount":99},[],{"intervention":51,"totalTrials":115,"cells":703},{"EARLY_PHASE1":704,"PHASE1":706,"PHASE2":715,"PHASE3":717,"PHASE4":719,"NA":721},{"trials":705,"activeCount":99},[],{"trials":707,"activeCount":115,"soonestReadout":50},[708],{"nctId":48,"briefTitle":49,"status":107,"phases":709,"primaryCompletion":50,"completion":50,"start":710,"enrollment":711,"conditions":712,"interventions":714},[87],"2016-03",35,[713],"Motor Neuron Disease, Upper",[51],{"trials":716,"activeCount":99},[],{"trials":718,"activeCount":99},[],{"trials":720,"activeCount":99},[],{"trials":722,"activeCount":99},[],{"intervention":79,"totalTrials":115,"cells":724},{"EARLY_PHASE1":725,"PHASE1":727,"PHASE2":738,"PHASE3":740,"PHASE4":742,"NA":744},{"trials":726,"activeCount":99},[],{"trials":728,"activeCount":115,"soonestReadout":74},[729],{"nctId":77,"briefTitle":78,"status":281,"phases":730,"primaryCompletion":74,"completion":74,"start":731,"enrollment":670,"conditions":732,"interventions":737},[87],"2019-11-20",[733,734,735,736],"Rotator Cuff Tears","Muscle Atrophy or Weakness","Tendon Rupture - Shoulder","Safety Issues",[79],{"trials":739,"activeCount":99},[],{"trials":741,"activeCount":99},[],{"trials":743,"activeCount":99},[],{"trials":745,"activeCount":99},[],{"intervention":747,"totalTrials":115,"cells":748},"ONT01 is a small molecule CD11b modulator.",{"EARLY_PHASE1":749,"PHASE1":768,"PHASE2":770,"PHASE3":772,"PHASE4":774,"NA":776},{"trials":750,"activeCount":115,"soonestReadout":755},[751],{"nctId":752,"briefTitle":753,"status":240,"phases":754,"primaryCompletion":755,"completion":755,"start":756,"enrollment":757,"conditions":758,"interventions":767},"NCT07107659","Safety and Efficacy of ONT01 in Lupus",[86],"2030-05","2026-09-04",61,[759,760,761,762,763,764,765,766],"Lupus Nephritis (LN)","Lupus Nephritis - WHO Class III","Lupus Nephritis - WHO Class IV","Lupus Nephritis - World Health Organization (WHO) Class III","Lupus","SLE","Systemic Lupus Erythematosus","Systemic Lupus Erythematosus (Disorder)",[747],{"trials":769,"activeCount":99},[],{"trials":771,"activeCount":99},[],{"trials":773,"activeCount":99},[],{"trials":775,"activeCount":99},[],{"trials":777,"activeCount":99},[],{"intervention":779,"totalTrials":115,"cells":780},"Bone Marrow Aspirate",{"EARLY_PHASE1":781,"PHASE1":783,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":791},{"trials":782,"activeCount":99},[],{"trials":784,"activeCount":99},[],{"trials":786,"activeCount":99},[],{"trials":788,"activeCount":99},[],{"trials":790,"activeCount":99},[],{"trials":792,"activeCount":115,"soonestReadout":797},[793],{"nctId":794,"briefTitle":795,"status":240,"phases":796,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":801,"interventions":806},"NCT06893302","Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy",[91],"2028-04","2029-04","2026-06",50,[802,803,804,805],"Chondral Lesion of the Knee","Meniscal Injuries","Cartilage Defects of the Knee","Osteoarthritis (OA) of the Knee",[779],{"intervention":808,"totalTrials":27,"cells":809},"Bupivacaine",{"EARLY_PHASE1":810,"PHASE1":812,"PHASE2":814,"PHASE3":816,"PHASE4":818,"NA":908},{"trials":811,"activeCount":99},[],{"trials":813,"activeCount":99},[],{"trials":815,"activeCount":99},[],{"trials":817,"activeCount":99},[],{"trials":819,"activeCount":99},[820,833,848,859,874,885,899],{"nctId":821,"briefTitle":822,"status":451,"phases":823,"primaryCompletion":824,"completion":825,"start":826,"enrollment":827,"conditions":828,"interventions":832},"NCT03272139","Interscalene Block Versus Superior Trunk Block",[90],"2018-12-30","2019-07-09","2017-09-28",126,[829,18,830,831],"Joint Disease","Pain, Acute","Pain, Chronic",[808],{"nctId":834,"briefTitle":835,"status":451,"phases":836,"primaryCompletion":837,"completion":838,"start":839,"enrollment":840,"conditions":841,"interventions":844},"NCT05980546","Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty",[90],"2025-09-05","2025-09-11","2023-06-07",244,[842,843,15],"Total Knee Replacement","Genicular Nerve Block",[808,845,846,847],"Dexamethasone","Fentanyl","Mepivacaine",{"nctId":849,"briefTitle":850,"status":451,"phases":851,"primaryCompletion":852,"completion":853,"start":854,"enrollment":855,"conditions":856,"interventions":858},"NCT03090152","Minimal Opioid Use After Total Hip Replacement (THR)",[90],"2019-06-28","2019-09-27","2017-03-08",180,[857],"Osteoarthritis, Hip",[808],{"nctId":860,"briefTitle":861,"status":451,"phases":862,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":866,"interventions":867},"NCT02292082","The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)",[90],"2016-08","2014-11",111,[26],[808,868,869,870,871,872,873,845],"Morphine","Methylprednisolone","Cefazolin","Normal saline","Midazolam","Propofol",{"nctId":875,"briefTitle":876,"status":451,"phases":877,"primaryCompletion":878,"completion":879,"start":880,"enrollment":881,"conditions":882,"interventions":884},"NCT03292926","A Novel Analgesia Technique for ACL Reconstruction",[90],"2020-03-06","2020-04-16","2017-10-04",78,[883],"Anterior Cruciate Ligament Injury",[808,845],{"nctId":886,"briefTitle":887,"status":451,"phases":888,"primaryCompletion":889,"completion":889,"start":890,"enrollment":891,"conditions":892,"interventions":894},"NCT02506660","Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy",[90],"2016-11","2015-08",128,[18,893],"Shoulder Arthroscopy",[808,895,896,897,898],"Perineural dexamethasone","Intravenous dexamethasone","Intravenous saline","Perineural saline",{"nctId":900,"briefTitle":901,"status":451,"phases":902,"primaryCompletion":903,"completion":903,"start":904,"enrollment":905,"conditions":906,"interventions":907},"NCT04156581","Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery",[90],"2022-06-18","2019-11-19",46,[15,23],[808,845],{"trials":909,"activeCount":99},[],{"intervention":845,"totalTrials":27,"cells":911},{"EARLY_PHASE1":912,"PHASE1":914,"PHASE2":925,"PHASE3":927,"PHASE4":929,"NA":974},{"trials":913,"activeCount":99},[],{"trials":915,"activeCount":99},[916],{"nctId":917,"briefTitle":918,"status":451,"phases":919,"primaryCompletion":478,"completion":920,"start":479,"enrollment":921,"conditions":922,"interventions":923},"NCT02198235","Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)",[87],"2014-02",90,[32],[845,924],"Buprenorphine",{"trials":926,"activeCount":99},[],{"trials":928,"activeCount":99},[],{"trials":930,"activeCount":99},[931,935,939,943,958,970],{"nctId":834,"briefTitle":835,"status":451,"phases":932,"primaryCompletion":837,"completion":838,"start":839,"enrollment":840,"conditions":933,"interventions":934},[90],[842,843,15],[808,845,846,847],{"nctId":860,"briefTitle":861,"status":451,"phases":936,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":937,"interventions":938},[90],[26],[808,868,869,870,871,872,873,845],{"nctId":875,"briefTitle":876,"status":451,"phases":940,"primaryCompletion":878,"completion":879,"start":880,"enrollment":881,"conditions":941,"interventions":942},[90],[883],[808,845],{"nctId":944,"briefTitle":945,"status":451,"phases":946,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":951,"interventions":953},"NCT03094663","Adductor Canal Block With Periarticular Injection and IPACK (ACB\u002FPAI\u002FIPACK) Versus Periarticular Injection (PAI)",[90],"2018-05-31","2018-09-01","2017-02-28",86,[952],"Knee Arthropathy",[954,869,870,955,956,957,845],"Bupivacaine with epinephrine","Bupivacaine with Dexamethasone","Bupivacaine 25cc","Bupivacaine 20cc",{"nctId":959,"briefTitle":960,"status":451,"phases":961,"primaryCompletion":962,"completion":963,"start":964,"enrollment":965,"conditions":966,"interventions":968},"NCT04047446","Liposomal Bupivacaine vs Dexamethasone ISB",[90],"2021-03-15","2021-03-19","2019-07-11",112,[967],"Shoulder Pain",[969,845],"Exparel 133 MG Per 10 ML",{"nctId":900,"briefTitle":901,"status":451,"phases":971,"primaryCompletion":903,"completion":903,"start":904,"enrollment":905,"conditions":972,"interventions":973},[90],[15,23],[808,845],{"trials":975,"activeCount":99},[],{"intervention":977,"totalTrials":95,"cells":978},"Intravenous tranexamic acid",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":985,"PHASE4":987,"NA":1013},{"trials":980,"activeCount":99},[],{"trials":982,"activeCount":99},[],{"trials":984,"activeCount":99},[],{"trials":986,"activeCount":99},[],{"trials":988,"activeCount":99},[989,1001],{"nctId":990,"briefTitle":991,"status":451,"phases":992,"primaryCompletion":993,"completion":994,"start":995,"enrollment":996,"conditions":997,"interventions":998},"NCT02540226","Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement",[90],"2018-12","2019-12","2015-11-19",76,[314],[977,999,897,1000],"Topical tranexamic acid","Topical saline",{"nctId":1002,"briefTitle":1003,"status":451,"phases":1004,"primaryCompletion":1005,"completion":1006,"start":1007,"enrollment":1008,"conditions":1009,"interventions":1010},"NCT01940523","Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical",[90],"2015-12-28","2017-05-16","2013-05",640,[26],[1011,1012],"Topical Tranexamic Acid","Intravenous Tranexamic Acid",{"trials":1014,"activeCount":99},[],{"intervention":999,"totalTrials":95,"cells":1016},{"EARLY_PHASE1":1017,"PHASE1":1019,"PHASE2":1021,"PHASE3":1023,"PHASE4":1025,"NA":1035},{"trials":1018,"activeCount":99},[],{"trials":1020,"activeCount":99},[],{"trials":1022,"activeCount":99},[],{"trials":1024,"activeCount":99},[],{"trials":1026,"activeCount":99},[1027,1031],{"nctId":990,"briefTitle":991,"status":451,"phases":1028,"primaryCompletion":993,"completion":994,"start":995,"enrollment":996,"conditions":1029,"interventions":1030},[90],[314],[977,999,897,1000],{"nctId":1002,"briefTitle":1003,"status":451,"phases":1032,"primaryCompletion":1005,"completion":1006,"start":1007,"enrollment":1008,"conditions":1033,"interventions":1034},[90],[26],[1011,1012],{"trials":1036,"activeCount":99},[],{"intervention":897,"totalTrials":95,"cells":1038},{"EARLY_PHASE1":1039,"PHASE1":1041,"PHASE2":1043,"PHASE3":1045,"PHASE4":1047,"NA":1057},{"trials":1040,"activeCount":99},[],{"trials":1042,"activeCount":99},[],{"trials":1044,"activeCount":99},[],{"trials":1046,"activeCount":99},[],{"trials":1048,"activeCount":99},[1049,1053],{"nctId":990,"briefTitle":991,"status":451,"phases":1050,"primaryCompletion":993,"completion":994,"start":995,"enrollment":996,"conditions":1051,"interventions":1052},[90],[314],[977,999,897,1000],{"nctId":886,"briefTitle":887,"status":451,"phases":1054,"primaryCompletion":889,"completion":889,"start":890,"enrollment":891,"conditions":1055,"interventions":1056},[90],[18,893],[808,895,896,897,898],{"trials":1058,"activeCount":99},[],{"intervention":847,"totalTrials":95,"cells":1060},{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1079,"PHASE4":1081,"NA":1087},{"trials":1062,"activeCount":99},[],{"trials":1064,"activeCount":99},[],{"trials":1066,"activeCount":99},[1067],{"nctId":1068,"briefTitle":1069,"status":646,"phases":1070,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":1073,"conditions":1074,"interventions":1076},"NCT03365752","Chloroprocaine Spinal for Outpatient Knee Surgery",[88],"2021-02-04","2018-06-24",39,[1075],"Knee Arthroscopy",[1077,847,1078],"Chloroprocaine","General Anesthetics",{"trials":1080,"activeCount":99},[],{"trials":1082,"activeCount":99},[1083],{"nctId":834,"briefTitle":835,"status":451,"phases":1084,"primaryCompletion":837,"completion":838,"start":839,"enrollment":840,"conditions":1085,"interventions":1086},[90],[842,843,15],[808,845,846,847],{"trials":1088,"activeCount":99},[],{"intervention":869,"totalTrials":95,"cells":1090},{"EARLY_PHASE1":1091,"PHASE1":1093,"PHASE2":1095,"PHASE3":1097,"PHASE4":1099,"NA":1109},{"trials":1092,"activeCount":99},[],{"trials":1094,"activeCount":99},[],{"trials":1096,"activeCount":99},[],{"trials":1098,"activeCount":99},[],{"trials":1100,"activeCount":99},[1101,1105],{"nctId":860,"briefTitle":861,"status":451,"phases":1102,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":1103,"interventions":1104},[90],[26],[808,868,869,870,871,872,873,845],{"nctId":944,"briefTitle":945,"status":451,"phases":1106,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":1107,"interventions":1108},[90],[952],[954,869,870,955,956,957,845],{"trials":1110,"activeCount":99},[],{"intervention":870,"totalTrials":95,"cells":1112},{"EARLY_PHASE1":1113,"PHASE1":1115,"PHASE2":1117,"PHASE3":1119,"PHASE4":1121,"NA":1131},{"trials":1114,"activeCount":99},[],{"trials":1116,"activeCount":99},[],{"trials":1118,"activeCount":99},[],{"trials":1120,"activeCount":99},[],{"trials":1122,"activeCount":99},[1123,1127],{"nctId":860,"briefTitle":861,"status":451,"phases":1124,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":1125,"interventions":1126},[90],[26],[808,868,869,870,871,872,873,845],{"nctId":944,"briefTitle":945,"status":451,"phases":1128,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":1129,"interventions":1130},[90],[952],[954,869,870,955,956,957,845],{"trials":1132,"activeCount":99},[],{"intervention":1134,"totalTrials":95,"cells":1135},"PRP",{"EARLY_PHASE1":1136,"PHASE1":1138,"PHASE2":1140,"PHASE3":1142,"PHASE4":1144,"NA":1166},{"trials":1137,"activeCount":99},[],{"trials":1139,"activeCount":99},[],{"trials":1141,"activeCount":99},[],{"trials":1143,"activeCount":99},[],{"trials":1145,"activeCount":99},[1146,1155],{"nctId":1147,"briefTitle":1148,"status":451,"phases":1149,"primaryCompletion":1150,"completion":1150,"start":1151,"enrollment":124,"conditions":1152,"interventions":1153},"NCT02984228","Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis",[90],"2020-11","2014-12",[26,967],[1134,1154],"Hyaluronic Acid",{"nctId":1156,"briefTitle":1157,"status":646,"phases":1158,"primaryCompletion":1159,"completion":1159,"start":1160,"enrollment":95,"conditions":1161,"interventions":1164},"NCT02978833","Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy",[90],"2017-06","2013-10-01",[1162,1163],"Tendinopathy","Hip Pain",[1134,1165],"Whole Blood",{"trials":1167,"activeCount":99},[],{"intervention":1154,"totalTrials":95,"cells":1169},{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1176,"PHASE4":1178,"NA":1193},{"trials":1171,"activeCount":99},[],{"trials":1173,"activeCount":99},[],{"trials":1175,"activeCount":99},[],{"trials":1177,"activeCount":99},[],{"trials":1179,"activeCount":99},[1180,1184],{"nctId":1147,"briefTitle":1148,"status":451,"phases":1181,"primaryCompletion":1150,"completion":1150,"start":1151,"enrollment":124,"conditions":1182,"interventions":1183},[90],[26,967],[1134,1154],{"nctId":1185,"briefTitle":1186,"status":451,"phases":1187,"primaryCompletion":1188,"completion":1188,"start":1189,"enrollment":1190,"conditions":1191,"interventions":1192},"NCT03245463","Evaluation of Methods of Teaching Self-management Strategies to Patients With Symptomatic Knee Osteoarthritis",[90],"2018-02-13","2017-08-09",24,[314],[1154],{"trials":1194,"activeCount":99},[],{"intervention":1196,"totalTrials":115,"cells":1197},"Midazolam, 2-5 mg IV + Glycopyrrolate, 0.1 mg IV + Ketamine, 10-20 mg + propofol as needed",{"EARLY_PHASE1":1198,"PHASE1":1200,"PHASE2":1202,"PHASE3":1204,"PHASE4":1206,"NA":1221},{"trials":1199,"activeCount":99},[],{"trials":1201,"activeCount":99},[],{"trials":1203,"activeCount":99},[],{"trials":1205,"activeCount":99},[],{"trials":1207,"activeCount":99},[1208],{"nctId":1209,"briefTitle":1210,"status":451,"phases":1211,"primaryCompletion":1212,"completion":1212,"start":1213,"enrollment":1214,"conditions":1215,"interventions":1220},"NCT02996591","Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery.",[90],"2017-05","2017-01",36,[1216,1217,1218,18,1219],"Nerve Block","General Anesthesia","Spinal Anesthesia","Postoperative Nausea and Vomiting",[1196],{"trials":1222,"activeCount":99},[],{"intervention":1224,"totalTrials":115,"cells":1225},"XIAFLEX",{"EARLY_PHASE1":1226,"PHASE1":1228,"PHASE2":1230,"PHASE3":1232,"PHASE4":1234,"NA":1246},{"trials":1227,"activeCount":99},[],{"trials":1229,"activeCount":99},[],{"trials":1231,"activeCount":99},[],{"trials":1233,"activeCount":99},[],{"trials":1235,"activeCount":99},[1236],{"nctId":1237,"briefTitle":1238,"status":451,"phases":1239,"primaryCompletion":1240,"completion":1241,"start":1242,"enrollment":35,"conditions":1243,"interventions":1245},"NCT01450397","MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex",[90],"2012-01","2012-02","2011-03",[1244],"Dupuytren's Disease",[1224],{"trials":1247,"activeCount":99},[],{"intervention":1249,"totalTrials":115,"cells":1250},"Duloxetine 60mg",{"EARLY_PHASE1":1251,"PHASE1":1253,"PHASE2":1255,"PHASE3":1257,"PHASE4":1259,"NA":1270},{"trials":1252,"activeCount":99},[],{"trials":1254,"activeCount":99},[],{"trials":1256,"activeCount":99},[],{"trials":1258,"activeCount":99},[],{"trials":1260,"activeCount":99},[1261],{"nctId":1262,"briefTitle":1263,"status":451,"phases":1264,"primaryCompletion":1265,"completion":890,"start":1266,"enrollment":1267,"conditions":1268,"interventions":1269},"NCT02005601","Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?",[90],"2015-05","2013-11",106,[29],[1249],{"trials":1271,"activeCount":99},[],{"intervention":1273,"totalTrials":115,"cells":1274},"Periarticular",{"EARLY_PHASE1":1275,"PHASE1":1277,"PHASE2":1279,"PHASE3":1281,"PHASE4":1283,"NA":1297},{"trials":1276,"activeCount":99},[],{"trials":1278,"activeCount":99},[],{"trials":1280,"activeCount":99},[],{"trials":1282,"activeCount":99},[],{"trials":1284,"activeCount":99},[1285],{"nctId":1286,"briefTitle":1287,"status":451,"phases":1288,"primaryCompletion":1289,"completion":1290,"start":1291,"enrollment":1292,"conditions":1293,"interventions":1295},"NCT04749615","Does PAI Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving ACB & IPACK?",[90],"2022-04-01","2022-07-01","2020-12-17",94,[1294],"Total Knee Athroplasty",[1273,1296],"Saline Control Periarticular",{"trials":1298,"activeCount":99},[],{"intervention":1296,"totalTrials":115,"cells":1300},{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1305,"PHASE3":1307,"PHASE4":1309,"NA":1315},{"trials":1302,"activeCount":99},[],{"trials":1304,"activeCount":99},[],{"trials":1306,"activeCount":99},[],{"trials":1308,"activeCount":99},[],{"trials":1310,"activeCount":99},[1311],{"nctId":1286,"briefTitle":1287,"status":451,"phases":1312,"primaryCompletion":1289,"completion":1290,"start":1291,"enrollment":1292,"conditions":1313,"interventions":1314},[90],[1294],[1273,1296],{"trials":1316,"activeCount":99},[],{"intervention":1318,"totalTrials":115,"cells":1319},"Hemostatic Matrix",{"EARLY_PHASE1":1320,"PHASE1":1322,"PHASE2":1324,"PHASE3":1326,"PHASE4":1328,"NA":1339},{"trials":1321,"activeCount":99},[],{"trials":1323,"activeCount":99},[],{"trials":1325,"activeCount":99},[],{"trials":1327,"activeCount":99},[],{"trials":1329,"activeCount":99},[1330],{"nctId":1331,"briefTitle":1332,"status":451,"phases":1333,"primaryCompletion":453,"completion":453,"start":1334,"enrollment":1335,"conditions":1336,"interventions":1338},"NCT00990288","The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery",[90],"2007-10",196,[1337],"Blood Loss",[1318],{"trials":1340,"activeCount":99},[],{"intervention":1342,"totalTrials":115,"cells":1343},"cannabidiol",{"EARLY_PHASE1":1344,"PHASE1":1346,"PHASE2":1348,"PHASE3":1350,"PHASE4":1352,"NA":1364},{"trials":1345,"activeCount":99},[],{"trials":1347,"activeCount":99},[],{"trials":1349,"activeCount":99},[],{"trials":1351,"activeCount":99},[],{"trials":1353,"activeCount":99},[1354],{"nctId":1355,"briefTitle":1356,"status":451,"phases":1357,"primaryCompletion":1358,"completion":1359,"start":1360,"enrollment":1361,"conditions":1362,"interventions":1363},"NCT04749628","Cannabidiol for Bilateral Total Knee Arthroplasty",[90],"2024-10-11","2025-01-08","2022-11-02",37,[23,15,21],[1342],{"trials":1365,"activeCount":99},[],{"intervention":1000,"totalTrials":115,"cells":1367},{"EARLY_PHASE1":1368,"PHASE1":1370,"PHASE2":1372,"PHASE3":1374,"PHASE4":1376,"NA":1382},{"trials":1369,"activeCount":99},[],{"trials":1371,"activeCount":99},[],{"trials":1373,"activeCount":99},[],{"trials":1375,"activeCount":99},[],{"trials":1377,"activeCount":99},[1378],{"nctId":990,"briefTitle":991,"status":451,"phases":1379,"primaryCompletion":993,"completion":994,"start":995,"enrollment":996,"conditions":1380,"interventions":1381},[90],[314],[977,999,897,1000],{"trials":1383,"activeCount":99},[],{"intervention":1385,"totalTrials":115,"cells":1386},"Colchicine",{"EARLY_PHASE1":1387,"PHASE1":1389,"PHASE2":1391,"PHASE3":1393,"PHASE4":1395,"NA":1408},{"trials":1388,"activeCount":99},[],{"trials":1390,"activeCount":99},[],{"trials":1392,"activeCount":99},[],{"trials":1394,"activeCount":99},[],{"trials":1396,"activeCount":99},[1397],{"nctId":1398,"briefTitle":1399,"status":1400,"phases":1401,"primaryCompletion":1402,"completion":1403,"start":1404,"enrollment":965,"conditions":1405,"interventions":1407},"NCT02926248","Effect of Colchicine on Range of Motion After Manipulation Under Anesthesia for the Stiff Total Knee Replacement","SUSPENDED",[90],"2020-03-21","2021-03","2016-05",[1406],"Manipulation Under Anesthesia",[1385],{"trials":1409,"activeCount":99},[],{"intervention":846,"totalTrials":115,"cells":1411},{"EARLY_PHASE1":1412,"PHASE1":1414,"PHASE2":1416,"PHASE3":1418,"PHASE4":1420,"NA":1426},{"trials":1413,"activeCount":99},[],{"trials":1415,"activeCount":99},[],{"trials":1417,"activeCount":99},[],{"trials":1419,"activeCount":99},[],{"trials":1421,"activeCount":99},[1422],{"nctId":834,"briefTitle":835,"status":451,"phases":1423,"primaryCompletion":837,"completion":838,"start":839,"enrollment":840,"conditions":1424,"interventions":1425},[90],[842,843,15],[808,845,846,847],{"trials":1427,"activeCount":99},[],{"intervention":1429,"totalTrials":115,"cells":1430},"Dexmedetomidine",{"EARLY_PHASE1":1431,"PHASE1":1433,"PHASE2":1435,"PHASE3":1437,"PHASE4":1439,"NA":1449},{"trials":1432,"activeCount":99},[],{"trials":1434,"activeCount":99},[],{"trials":1436,"activeCount":99},[],{"trials":1438,"activeCount":99},[],{"trials":1440,"activeCount":99},[1441],{"nctId":1442,"briefTitle":1443,"status":646,"phases":1444,"primaryCompletion":1445,"completion":1445,"start":1446,"enrollment":27,"conditions":1447,"interventions":1448},"NCT03378973","The Effects of Dexmedetomidine Dose on Motor Evoked Potentials",[90],"2019-10-17","2018-11-28",[113],[1429],{"trials":1450,"activeCount":99},[],{"intervention":460,"totalTrials":115,"cells":1452},{"EARLY_PHASE1":1453,"PHASE1":1455,"PHASE2":1457,"PHASE3":1459,"PHASE4":1461,"NA":1467},{"trials":1454,"activeCount":99},[],{"trials":1456,"activeCount":99},[],{"trials":1458,"activeCount":99},[],{"trials":1460,"activeCount":99},[],{"trials":1462,"activeCount":99},[1463],{"nctId":449,"briefTitle":450,"status":451,"phases":1464,"primaryCompletion":453,"completion":454,"start":455,"enrollment":456,"conditions":1465,"interventions":1466},[90],[458],[41,460],{"trials":1468,"activeCount":99},[],{"intervention":1470,"totalTrials":115,"cells":1471},"IV Saline",{"EARLY_PHASE1":1472,"PHASE1":1474,"PHASE2":1476,"PHASE3":1478,"PHASE4":1480,"NA":1493},{"trials":1473,"activeCount":99},[],{"trials":1475,"activeCount":99},[],{"trials":1477,"activeCount":99},[],{"trials":1479,"activeCount":99},[],{"trials":1481,"activeCount":99},[1482],{"nctId":1483,"briefTitle":1484,"status":451,"phases":1485,"primaryCompletion":1486,"completion":1486,"start":1404,"enrollment":1487,"conditions":1488,"interventions":1489},"NCT02688530","Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy",[90],"2017-11-19",140,[893,18],[1470,1490,1491,1492],"IV Dexamethasone 4mg","IV Dexamethasone 6mg","IV Dexamethasone 8mg",{"trials":1494,"activeCount":99},[],{"intervention":1490,"totalTrials":115,"cells":1496},{"EARLY_PHASE1":1497,"PHASE1":1499,"PHASE2":1501,"PHASE3":1503,"PHASE4":1505,"NA":1511},{"trials":1498,"activeCount":99},[],{"trials":1500,"activeCount":99},[],{"trials":1502,"activeCount":99},[],{"trials":1504,"activeCount":99},[],{"trials":1506,"activeCount":99},[1507],{"nctId":1483,"briefTitle":1484,"status":451,"phases":1508,"primaryCompletion":1486,"completion":1486,"start":1404,"enrollment":1487,"conditions":1509,"interventions":1510},[90],[893,18],[1470,1490,1491,1492],{"trials":1512,"activeCount":99},[],{"intervention":1491,"totalTrials":115,"cells":1514},{"EARLY_PHASE1":1515,"PHASE1":1517,"PHASE2":1519,"PHASE3":1521,"PHASE4":1523,"NA":1529},{"trials":1516,"activeCount":99},[],{"trials":1518,"activeCount":99},[],{"trials":1520,"activeCount":99},[],{"trials":1522,"activeCount":99},[],{"trials":1524,"activeCount":99},[1525],{"nctId":1483,"briefTitle":1484,"status":451,"phases":1526,"primaryCompletion":1486,"completion":1486,"start":1404,"enrollment":1487,"conditions":1527,"interventions":1528},[90],[893,18],[1470,1490,1491,1492],{"trials":1530,"activeCount":99},[],{"intervention":1492,"totalTrials":115,"cells":1532},{"EARLY_PHASE1":1533,"PHASE1":1535,"PHASE2":1537,"PHASE3":1539,"PHASE4":1541,"NA":1547},{"trials":1534,"activeCount":99},[],{"trials":1536,"activeCount":99},[],{"trials":1538,"activeCount":99},[],{"trials":1540,"activeCount":99},[],{"trials":1542,"activeCount":99},[1543],{"nctId":1483,"briefTitle":1484,"status":451,"phases":1544,"primaryCompletion":1486,"completion":1486,"start":1404,"enrollment":1487,"conditions":1545,"interventions":1546},[90],[893,18],[1470,1490,1491,1492],{"trials":1548,"activeCount":99},[],{"intervention":1550,"totalTrials":115,"cells":1551},"Evicel fibrin sealant",{"EARLY_PHASE1":1552,"PHASE1":1554,"PHASE2":1556,"PHASE3":1558,"PHASE4":1560,"NA":1572},{"trials":1553,"activeCount":99},[],{"trials":1555,"activeCount":99},[],{"trials":1557,"activeCount":99},[],{"trials":1559,"activeCount":99},[],{"trials":1561,"activeCount":99},[1562],{"nctId":1563,"briefTitle":1564,"status":451,"phases":1565,"primaryCompletion":1566,"completion":1567,"start":1568,"enrollment":1569,"conditions":1570,"interventions":1571},"NCT01235715","The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery",[90],"2012-03","2012-09","2010-09",200,[26],[1550],{"trials":1573,"activeCount":99},[],{"intervention":868,"totalTrials":115,"cells":1575},{"EARLY_PHASE1":1576,"PHASE1":1578,"PHASE2":1580,"PHASE3":1582,"PHASE4":1584,"NA":1590},{"trials":1577,"activeCount":99},[],{"trials":1579,"activeCount":99},[],{"trials":1581,"activeCount":99},[],{"trials":1583,"activeCount":99},[],{"trials":1585,"activeCount":99},[1586],{"nctId":860,"briefTitle":861,"status":451,"phases":1587,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":1588,"interventions":1589},[90],[26],[808,868,869,870,871,872,873,845],{"trials":1591,"activeCount":99},[],{"intervention":871,"totalTrials":115,"cells":1593},{"EARLY_PHASE1":1594,"PHASE1":1596,"PHASE2":1598,"PHASE3":1600,"PHASE4":1602,"NA":1608},{"trials":1595,"activeCount":99},[],{"trials":1597,"activeCount":99},[],{"trials":1599,"activeCount":99},[],{"trials":1601,"activeCount":99},[],{"trials":1603,"activeCount":99},[1604],{"nctId":860,"briefTitle":861,"status":451,"phases":1605,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":1606,"interventions":1607},[90],[26],[808,868,869,870,871,872,873,845],{"trials":1609,"activeCount":99},[],{"intervention":873,"totalTrials":115,"cells":1611},{"EARLY_PHASE1":1612,"PHASE1":1614,"PHASE2":1616,"PHASE3":1618,"PHASE4":1620,"NA":1626},{"trials":1613,"activeCount":99},[],{"trials":1615,"activeCount":99},[],{"trials":1617,"activeCount":99},[],{"trials":1619,"activeCount":99},[],{"trials":1621,"activeCount":99},[1622],{"nctId":860,"briefTitle":861,"status":451,"phases":1623,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":1624,"interventions":1625},[90],[26],[808,868,869,870,871,872,873,845],{"trials":1627,"activeCount":99},[],{"intervention":1629,"totalTrials":115,"cells":1630},"Ofirmev",{"EARLY_PHASE1":1631,"PHASE1":1633,"PHASE2":1635,"PHASE3":1637,"PHASE4":1639,"NA":1651},{"trials":1632,"activeCount":99},[],{"trials":1634,"activeCount":99},[],{"trials":1636,"activeCount":99},[],{"trials":1638,"activeCount":99},[],{"trials":1640,"activeCount":99},[1641],{"nctId":1642,"briefTitle":1643,"status":451,"phases":1644,"primaryCompletion":1645,"completion":1645,"start":1213,"enrollment":1646,"conditions":1647,"interventions":1649},"NCT03020875","IV vs Oral Acetaminophen in Spine Fusion Perioperative Care",[90],"2025-02-03",166,[1648],"Multimodal Analgesic Approach",[1629,1650],"Per Os Acetaminophen",{"trials":1652,"activeCount":99},[],{"intervention":1650,"totalTrials":115,"cells":1654},{"EARLY_PHASE1":1655,"PHASE1":1657,"PHASE2":1659,"PHASE3":1661,"PHASE4":1663,"NA":1669},{"trials":1656,"activeCount":99},[],{"trials":1658,"activeCount":99},[],{"trials":1660,"activeCount":99},[],{"trials":1662,"activeCount":99},[],{"trials":1664,"activeCount":99},[1665],{"nctId":1642,"briefTitle":1643,"status":451,"phases":1666,"primaryCompletion":1645,"completion":1645,"start":1213,"enrollment":1646,"conditions":1667,"interventions":1668},[90],[1648],[1629,1650],{"trials":1670,"activeCount":99},[],{"intervention":1672,"totalTrials":115,"cells":1673},"Amino Acid",{"EARLY_PHASE1":1674,"PHASE1":1676,"PHASE2":1678,"PHASE3":1680,"PHASE4":1682,"NA":1693},{"trials":1675,"activeCount":99},[],{"trials":1677,"activeCount":99},[],{"trials":1679,"activeCount":99},[],{"trials":1681,"activeCount":99},[],{"trials":1683,"activeCount":99},[1684],{"nctId":1685,"briefTitle":1686,"status":646,"phases":1687,"primaryCompletion":1688,"completion":1688,"start":1689,"enrollment":800,"conditions":1690,"interventions":1692},"NCT02926235","Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty",[90],"2022-05-14","2016-04",[1691],"Quad Atrophy",[1672],{"trials":1694,"activeCount":99},[],{"intervention":1696,"totalTrials":115,"cells":1697},"Genicular Nerve Block with bupivacaine and preservative free dexamethasone",{"EARLY_PHASE1":1698,"PHASE1":1700,"PHASE2":1702,"PHASE3":1704,"PHASE4":1706,"NA":1719},{"trials":1699,"activeCount":99},[],{"trials":1701,"activeCount":99},[],{"trials":1703,"activeCount":99},[],{"trials":1705,"activeCount":99},[],{"trials":1707,"activeCount":99},[1708],{"nctId":1709,"briefTitle":1710,"status":451,"phases":1711,"primaryCompletion":1712,"completion":1713,"start":1714,"enrollment":1715,"conditions":1716,"interventions":1718},"NCT05720949","Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery",[90],"2024-11-26","2024-12-02","2023-01-12",192,[1717,364],"ACL",[1696],{"trials":1720,"activeCount":99},[],{"intervention":1722,"totalTrials":115,"cells":1723},"Dronabinol 5mg Cap",{"EARLY_PHASE1":1724,"PHASE1":1726,"PHASE2":1728,"PHASE3":1730,"PHASE4":1732,"NA":1744},{"trials":1725,"activeCount":99},[],{"trials":1727,"activeCount":99},[],{"trials":1729,"activeCount":99},[],{"trials":1731,"activeCount":99},[],{"trials":1733,"activeCount":99},[1734],{"nctId":1735,"briefTitle":1736,"status":451,"phases":1737,"primaryCompletion":1738,"completion":1739,"start":1740,"enrollment":1741,"conditions":1742,"interventions":1743},"NCT04734080","Dronabinol in Total Knee Arthroplasty (TKA)",[90],"2023-10-06","2024-04-01","2021-03-09",114,[29,15],[1722],{"trials":1745,"activeCount":99},[],{"intervention":1747,"totalTrials":115,"cells":1748},"E-Aminocaproic acid",{"EARLY_PHASE1":1749,"PHASE1":1751,"PHASE2":1753,"PHASE3":1755,"PHASE4":1757,"NA":1769},{"trials":1750,"activeCount":99},[],{"trials":1752,"activeCount":99},[],{"trials":1754,"activeCount":99},[],{"trials":1756,"activeCount":99},[],{"trials":1758,"activeCount":99},[1759],{"nctId":1760,"briefTitle":1761,"status":451,"phases":1762,"primaryCompletion":1763,"completion":1763,"start":1764,"enrollment":11,"conditions":1765,"interventions":1768},"NCT02257580","The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO",[90],"2020-10-26","2015-04-01",[1766,1767],"E-Aminocaproic Acid","Bilateral Varus Rotational Osteotomy",[1747],{"trials":1770,"activeCount":99},[],{"intervention":1772,"totalTrials":115,"cells":1773},"Ondansetron",{"EARLY_PHASE1":1774,"PHASE1":1776,"PHASE2":1778,"PHASE3":1780,"PHASE4":1782,"NA":1795},{"trials":1775,"activeCount":99},[],{"trials":1777,"activeCount":99},[],{"trials":1779,"activeCount":99},[],{"trials":1781,"activeCount":99},[],{"trials":1783,"activeCount":99},[1784],{"nctId":1785,"briefTitle":1786,"status":451,"phases":1787,"primaryCompletion":1788,"completion":1789,"start":1790,"enrollment":1791,"conditions":1792,"interventions":1794},"NCT00878228","Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy",[90],"2010-01","2010-02","2009-04",98,[1793],"Nausea and Vomiting, Postoperative",[1772],{"trials":1796,"activeCount":99},[],{"intervention":1798,"totalTrials":115,"cells":1799},"Cymbalta",{"EARLY_PHASE1":1800,"PHASE1":1802,"PHASE2":1804,"PHASE3":1806,"PHASE4":1808,"NA":1819},{"trials":1801,"activeCount":99},[],{"trials":1803,"activeCount":99},[],{"trials":1805,"activeCount":99},[],{"trials":1807,"activeCount":99},[],{"trials":1809,"activeCount":99},[1810],{"nctId":1811,"briefTitle":1812,"status":451,"phases":1813,"primaryCompletion":1814,"completion":1815,"start":826,"enrollment":1816,"conditions":1817,"interventions":1818},"NCT03271151","Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty",[90],"2020-12-03","2021-02-19",160,[829,830,831],[1798],{"trials":1820,"activeCount":99},[],{"intervention":954,"totalTrials":115,"cells":1822},{"EARLY_PHASE1":1823,"PHASE1":1825,"PHASE2":1827,"PHASE3":1829,"PHASE4":1831,"NA":1837},{"trials":1824,"activeCount":99},[],{"trials":1826,"activeCount":99},[],{"trials":1828,"activeCount":99},[],{"trials":1830,"activeCount":99},[],{"trials":1832,"activeCount":99},[1833],{"nctId":944,"briefTitle":945,"status":451,"phases":1834,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":1835,"interventions":1836},[90],[952],[954,869,870,955,956,957,845],{"trials":1838,"activeCount":99},[],{"intervention":955,"totalTrials":115,"cells":1840},{"EARLY_PHASE1":1841,"PHASE1":1843,"PHASE2":1845,"PHASE3":1847,"PHASE4":1849,"NA":1855},{"trials":1842,"activeCount":99},[],{"trials":1844,"activeCount":99},[],{"trials":1846,"activeCount":99},[],{"trials":1848,"activeCount":99},[],{"trials":1850,"activeCount":99},[1851],{"nctId":944,"briefTitle":945,"status":451,"phases":1852,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":1853,"interventions":1854},[90],[952],[954,869,870,955,956,957,845],{"trials":1856,"activeCount":99},[],{"intervention":956,"totalTrials":115,"cells":1858},{"EARLY_PHASE1":1859,"PHASE1":1861,"PHASE2":1863,"PHASE3":1865,"PHASE4":1867,"NA":1873},{"trials":1860,"activeCount":99},[],{"trials":1862,"activeCount":99},[],{"trials":1864,"activeCount":99},[],{"trials":1866,"activeCount":99},[],{"trials":1868,"activeCount":99},[1869],{"nctId":944,"briefTitle":945,"status":451,"phases":1870,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":1871,"interventions":1872},[90],[952],[954,869,870,955,956,957,845],{"trials":1874,"activeCount":99},[],{"intervention":957,"totalTrials":115,"cells":1876},{"EARLY_PHASE1":1877,"PHASE1":1879,"PHASE2":1881,"PHASE3":1883,"PHASE4":1885,"NA":1891},{"trials":1878,"activeCount":99},[],{"trials":1880,"activeCount":99},[],{"trials":1882,"activeCount":99},[],{"trials":1884,"activeCount":99},[],{"trials":1886,"activeCount":99},[1887],{"nctId":944,"briefTitle":945,"status":451,"phases":1888,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":1889,"interventions":1890},[90],[952],[954,869,870,955,956,957,845],{"trials":1892,"activeCount":99},[],{"intervention":1894,"totalTrials":115,"cells":1895},"Kenalog Injectable Product",{"EARLY_PHASE1":1896,"PHASE1":1898,"PHASE2":1900,"PHASE3":1902,"PHASE4":1904,"NA":1916},{"trials":1897,"activeCount":99},[],{"trials":1899,"activeCount":99},[],{"trials":1901,"activeCount":99},[],{"trials":1903,"activeCount":99},[],{"trials":1905,"activeCount":99},[1906],{"nctId":1907,"briefTitle":1908,"status":1909,"phases":1910,"primaryCompletion":1911,"completion":1911,"start":1912,"enrollment":99,"conditions":1913,"interventions":1914},"NCT03245671","Particulate vs. Nonparticulate Epidural Steroid Injections for Lumbar Foraminal Stenosis","WITHDRAWN",[90],"2019-04","2017-12",[499],[1894,1915],"Decadron Phosphate, Injectable",{"trials":1917,"activeCount":99},[],{"intervention":1915,"totalTrials":115,"cells":1919},{"EARLY_PHASE1":1920,"PHASE1":1922,"PHASE2":1924,"PHASE3":1926,"PHASE4":1928,"NA":1934},{"trials":1921,"activeCount":99},[],{"trials":1923,"activeCount":99},[],{"trials":1925,"activeCount":99},[],{"trials":1927,"activeCount":99},[],{"trials":1929,"activeCount":99},[1930],{"nctId":1907,"briefTitle":1908,"status":1909,"phases":1931,"primaryCompletion":1911,"completion":1911,"start":1912,"enrollment":99,"conditions":1932,"interventions":1933},[90],[499],[1894,1915],{"trials":1935,"activeCount":99},[],{"intervention":1937,"totalTrials":115,"cells":1938},"MIDCAB",{"EARLY_PHASE1":1939,"PHASE1":1941,"PHASE2":1943,"PHASE3":1945,"PHASE4":1947,"NA":1959},{"trials":1940,"activeCount":99},[],{"trials":1942,"activeCount":99},[],{"trials":1944,"activeCount":99},[],{"trials":1946,"activeCount":99},[],{"trials":1948,"activeCount":99},[1949],{"nctId":1950,"briefTitle":1951,"status":451,"phases":1952,"primaryCompletion":1953,"completion":1953,"start":1954,"enrollment":670,"conditions":1955,"interventions":1958},"NCT05368012","MIDCAB (Mid-Calf Block) for Foot Surgery",[90],"2022-11-29","2022-07-21",[1956,1957],"Ankle Surgery","Foot Surgery",[1937],{"trials":1960,"activeCount":99},[],{"intervention":895,"totalTrials":115,"cells":1962},{"EARLY_PHASE1":1963,"PHASE1":1965,"PHASE2":1967,"PHASE3":1969,"PHASE4":1971,"NA":1977},{"trials":1964,"activeCount":99},[],{"trials":1966,"activeCount":99},[],{"trials":1968,"activeCount":99},[],{"trials":1970,"activeCount":99},[],{"trials":1972,"activeCount":99},[1973],{"nctId":886,"briefTitle":887,"status":451,"phases":1974,"primaryCompletion":889,"completion":889,"start":890,"enrollment":891,"conditions":1975,"interventions":1976},[90],[18,893],[808,895,896,897,898],{"trials":1978,"activeCount":99},[],{"intervention":896,"totalTrials":115,"cells":1980},{"EARLY_PHASE1":1981,"PHASE1":1983,"PHASE2":1985,"PHASE3":1987,"PHASE4":1989,"NA":1995},{"trials":1982,"activeCount":99},[],{"trials":1984,"activeCount":99},[],{"trials":1986,"activeCount":99},[],{"trials":1988,"activeCount":99},[],{"trials":1990,"activeCount":99},[1991],{"nctId":886,"briefTitle":887,"status":451,"phases":1992,"primaryCompletion":889,"completion":889,"start":890,"enrollment":891,"conditions":1993,"interventions":1994},[90],[18,893],[808,895,896,897,898],{"trials":1996,"activeCount":99},[],{"intervention":898,"totalTrials":115,"cells":1998},{"EARLY_PHASE1":1999,"PHASE1":2001,"PHASE2":2003,"PHASE3":2005,"PHASE4":2007,"NA":2013},{"trials":2000,"activeCount":99},[],{"trials":2002,"activeCount":99},[],{"trials":2004,"activeCount":99},[],{"trials":2006,"activeCount":99},[],{"trials":2008,"activeCount":99},[2009],{"nctId":886,"briefTitle":887,"status":451,"phases":2010,"primaryCompletion":889,"completion":889,"start":890,"enrollment":891,"conditions":2011,"interventions":2012},[90],[18,893],[808,895,896,897,898],{"trials":2014,"activeCount":99},[],{"intervention":2016,"totalTrials":115,"cells":2017},"Bupivacaine Only",{"EARLY_PHASE1":2018,"PHASE1":2020,"PHASE2":2022,"PHASE3":2024,"PHASE4":2026,"NA":2039},{"trials":2019,"activeCount":99},[],{"trials":2021,"activeCount":99},[],{"trials":2023,"activeCount":99},[],{"trials":2025,"activeCount":99},[],{"trials":2027,"activeCount":99},[2028],{"nctId":2029,"briefTitle":2030,"status":451,"phases":2031,"primaryCompletion":864,"completion":1151,"start":2032,"enrollment":2033,"conditions":2034,"interventions":2036},"NCT01586806","Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction",[90],"2012-07",195,[411,2035],"Regional Anesthesia, Saphenous Nerve Block",[2016,2037,2038],"Bupivacaine with 1 mg of Dexamethasone","Bupivacaine with 4 mg of Dexamethasone",{"trials":2040,"activeCount":99},[],{"intervention":2037,"totalTrials":115,"cells":2042},{"EARLY_PHASE1":2043,"PHASE1":2045,"PHASE2":2047,"PHASE3":2049,"PHASE4":2051,"NA":2057},{"trials":2044,"activeCount":99},[],{"trials":2046,"activeCount":99},[],{"trials":2048,"activeCount":99},[],{"trials":2050,"activeCount":99},[],{"trials":2052,"activeCount":99},[2053],{"nctId":2029,"briefTitle":2030,"status":451,"phases":2054,"primaryCompletion":864,"completion":1151,"start":2032,"enrollment":2033,"conditions":2055,"interventions":2056},[90],[411,2035],[2016,2037,2038],{"trials":2058,"activeCount":99},[],{"intervention":2038,"totalTrials":115,"cells":2060},{"EARLY_PHASE1":2061,"PHASE1":2063,"PHASE2":2065,"PHASE3":2067,"PHASE4":2069,"NA":2075},{"trials":2062,"activeCount":99},[],{"trials":2064,"activeCount":99},[],{"trials":2066,"activeCount":99},[],{"trials":2068,"activeCount":99},[],{"trials":2070,"activeCount":99},[2071],{"nctId":2029,"briefTitle":2030,"status":451,"phases":2072,"primaryCompletion":864,"completion":1151,"start":2032,"enrollment":2033,"conditions":2073,"interventions":2074},[90],[411,2035],[2016,2037,2038],{"trials":2076,"activeCount":99},[],{"intervention":1165,"totalTrials":115,"cells":2078},{"EARLY_PHASE1":2079,"PHASE1":2081,"PHASE2":2083,"PHASE3":2085,"PHASE4":2087,"NA":2093},{"trials":2080,"activeCount":99},[],{"trials":2082,"activeCount":99},[],{"trials":2084,"activeCount":99},[],{"trials":2086,"activeCount":99},[],{"trials":2088,"activeCount":99},[2089],{"nctId":1156,"briefTitle":1157,"status":646,"phases":2090,"primaryCompletion":1159,"completion":1159,"start":1160,"enrollment":95,"conditions":2091,"interventions":2092},[90],[1162,1163],[1134,1165],{"trials":2094,"activeCount":99},[],{"intervention":969,"totalTrials":115,"cells":2096},{"EARLY_PHASE1":2097,"PHASE1":2099,"PHASE2":2101,"PHASE3":2103,"PHASE4":2105,"NA":2111},{"trials":2098,"activeCount":99},[],{"trials":2100,"activeCount":99},[],{"trials":2102,"activeCount":99},[],{"trials":2104,"activeCount":99},[],{"trials":2106,"activeCount":99},[2107],{"nctId":959,"briefTitle":960,"status":451,"phases":2108,"primaryCompletion":962,"completion":963,"start":964,"enrollment":965,"conditions":2109,"interventions":2110},[90],[967],[969,845],{"trials":2112,"activeCount":99},[],{"intervention":2114,"totalTrials":115,"cells":2115},"Bupivacaine + dexamethasone",{"EARLY_PHASE1":2116,"PHASE1":2118,"PHASE2":2120,"PHASE3":2122,"PHASE4":2134,"NA":2136},{"trials":2117,"activeCount":99},[],{"trials":2119,"activeCount":99},[],{"trials":2121,"activeCount":99},[],{"trials":2123,"activeCount":99},[2124],{"nctId":2125,"briefTitle":2126,"status":451,"phases":2127,"primaryCompletion":2128,"completion":2129,"start":2130,"enrollment":111,"conditions":2131,"interventions":2133},"NCT03432650","Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy",[89],"2020-12-20","2021-09-09","2018-06-01",[2132],"Hip Disease",[2114],{"trials":2135,"activeCount":99},[],{"trials":2137,"activeCount":99},[],{"intervention":2139,"totalTrials":115,"cells":2140},"Synvisc",{"EARLY_PHASE1":2141,"PHASE1":2143,"PHASE2":2145,"PHASE3":2147,"PHASE4":2159,"NA":2161},{"trials":2142,"activeCount":99},[],{"trials":2144,"activeCount":99},[],{"trials":2146,"activeCount":99},[],{"trials":2148,"activeCount":99},[2149],{"nctId":2150,"briefTitle":2151,"status":451,"phases":2152,"primaryCompletion":2153,"completion":2153,"start":2154,"enrollment":1569,"conditions":2155,"interventions":2156},"NCT00398866","A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb",[89],"2013-03","2006-08",[26],[2139,2157,2158],"Bupivicaine","Kenalog",{"trials":2160,"activeCount":99},[],{"trials":2162,"activeCount":99},[],{"intervention":2157,"totalTrials":115,"cells":2164},{"EARLY_PHASE1":2165,"PHASE1":2167,"PHASE2":2169,"PHASE3":2171,"PHASE4":2177,"NA":2179},{"trials":2166,"activeCount":99},[],{"trials":2168,"activeCount":99},[],{"trials":2170,"activeCount":99},[],{"trials":2172,"activeCount":99},[2173],{"nctId":2150,"briefTitle":2151,"status":451,"phases":2174,"primaryCompletion":2153,"completion":2153,"start":2154,"enrollment":1569,"conditions":2175,"interventions":2176},[89],[26],[2139,2157,2158],{"trials":2178,"activeCount":99},[],{"trials":2180,"activeCount":99},[],{"intervention":2158,"totalTrials":115,"cells":2182},{"EARLY_PHASE1":2183,"PHASE1":2185,"PHASE2":2187,"PHASE3":2189,"PHASE4":2195,"NA":2197},{"trials":2184,"activeCount":99},[],{"trials":2186,"activeCount":99},[],{"trials":2188,"activeCount":99},[],{"trials":2190,"activeCount":99},[2191],{"nctId":2150,"briefTitle":2151,"status":451,"phases":2192,"primaryCompletion":2153,"completion":2153,"start":2154,"enrollment":1569,"conditions":2193,"interventions":2194},[89],[26],[2139,2157,2158],{"trials":2196,"activeCount":99},[],{"trials":2198,"activeCount":99},[],{"intervention":2200,"totalTrials":115,"cells":2201},"Hyalgan",{"EARLY_PHASE1":2202,"PHASE1":2204,"PHASE2":2206,"PHASE3":2208,"PHASE4":2217,"NA":2219},{"trials":2203,"activeCount":99},[],{"trials":2205,"activeCount":99},[],{"trials":2207,"activeCount":99},[],{"trials":2209,"activeCount":99},[2210],{"nctId":2211,"briefTitle":2212,"status":646,"phases":2213,"primaryCompletion":628,"start":2214,"enrollment":285,"conditions":2215,"interventions":2216},"NCT00323778","Prospective Assessment of the Efficacy of Hyaluronate Knee Injections in Patients With Osteoarthritis",[89],"2006-05",[21],[2200],{"trials":2218,"activeCount":99},[],{"trials":2220,"activeCount":99},[],{"intervention":2222,"totalTrials":115,"cells":2223},"Hydroxychloroquine",{"EARLY_PHASE1":2224,"PHASE1":2226,"PHASE2":2228,"PHASE3":2230,"PHASE4":2241,"NA":2243},{"trials":2225,"activeCount":99},[],{"trials":2227,"activeCount":99},[],{"trials":2229,"activeCount":99},[],{"trials":2231,"activeCount":99},[2232],{"nctId":2233,"briefTitle":2234,"status":646,"phases":2235,"primaryCompletion":2236,"completion":2236,"start":2237,"enrollment":2238,"conditions":2239,"interventions":2240},"NCT01784523","Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients",[89],"2015-09-30","2013-02",11,[34],[2222],{"trials":2242,"activeCount":99},[],{"trials":2244,"activeCount":99},[],{"intervention":2246,"totalTrials":115,"cells":2247},"Fluvastatin",{"EARLY_PHASE1":2248,"PHASE1":2250,"PHASE2":2252,"PHASE3":2263,"PHASE4":2265,"NA":2267},{"trials":2249,"activeCount":99},[],{"trials":2251,"activeCount":99},[],{"trials":2253,"activeCount":99},[2254],{"nctId":2255,"briefTitle":2256,"status":451,"phases":2257,"primaryCompletion":2258,"completion":2237,"start":2259,"enrollment":2260,"conditions":2261,"interventions":2262},"NCT00674297","Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients",[88],"2011-07","2008-05",41,[34],[2246],{"trials":2264,"activeCount":99},[],{"trials":2266,"activeCount":99},[],{"trials":2268,"activeCount":99},[],{"intervention":2270,"totalTrials":115,"cells":2271},"Ketamine Infusion + Epidural",{"EARLY_PHASE1":2272,"PHASE1":2274,"PHASE2":2276,"PHASE3":2289,"PHASE4":2291,"NA":2293},{"trials":2273,"activeCount":99},[],{"trials":2275,"activeCount":99},[],{"trials":2277,"activeCount":99},[2278],{"nctId":2279,"briefTitle":2280,"status":646,"phases":2281,"primaryCompletion":2282,"completion":2282,"start":2283,"enrollment":615,"conditions":2284,"interventions":2285},"NCT02094352","Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome",[88],"2015-04-20","2014-03-24",[287],[2270,2286,2287,2288],"Control Group + Epidural","Ketamine Booster","Control Group Booster",{"trials":2290,"activeCount":99},[],{"trials":2292,"activeCount":99},[],{"trials":2294,"activeCount":99},[],{"intervention":2286,"totalTrials":115,"cells":2296},{"EARLY_PHASE1":2297,"PHASE1":2299,"PHASE2":2301,"PHASE3":2307,"PHASE4":2309,"NA":2311},{"trials":2298,"activeCount":99},[],{"trials":2300,"activeCount":99},[],{"trials":2302,"activeCount":99},[2303],{"nctId":2279,"briefTitle":2280,"status":646,"phases":2304,"primaryCompletion":2282,"completion":2282,"start":2283,"enrollment":615,"conditions":2305,"interventions":2306},[88],[287],[2270,2286,2287,2288],{"trials":2308,"activeCount":99},[],{"trials":2310,"activeCount":99},[],{"trials":2312,"activeCount":99},[],{"intervention":2287,"totalTrials":115,"cells":2314},{"EARLY_PHASE1":2315,"PHASE1":2317,"PHASE2":2319,"PHASE3":2325,"PHASE4":2327,"NA":2329},{"trials":2316,"activeCount":99},[],{"trials":2318,"activeCount":99},[],{"trials":2320,"activeCount":99},[2321],{"nctId":2279,"briefTitle":2280,"status":646,"phases":2322,"primaryCompletion":2282,"completion":2282,"start":2283,"enrollment":615,"conditions":2323,"interventions":2324},[88],[287],[2270,2286,2287,2288],{"trials":2326,"activeCount":99},[],{"trials":2328,"activeCount":99},[],{"trials":2330,"activeCount":99},[],{"intervention":2288,"totalTrials":115,"cells":2332},{"EARLY_PHASE1":2333,"PHASE1":2335,"PHASE2":2337,"PHASE3":2343,"PHASE4":2345,"NA":2347},{"trials":2334,"activeCount":99},[],{"trials":2336,"activeCount":99},[],{"trials":2338,"activeCount":99},[2339],{"nctId":2279,"briefTitle":2280,"status":646,"phases":2340,"primaryCompletion":2282,"completion":2282,"start":2283,"enrollment":615,"conditions":2341,"interventions":2342},[88],[287],[2270,2286,2287,2288],{"trials":2344,"activeCount":99},[],{"trials":2346,"activeCount":99},[],{"trials":2348,"activeCount":99},[],{"intervention":1077,"totalTrials":115,"cells":2350},{"EARLY_PHASE1":2351,"PHASE1":2353,"PHASE2":2355,"PHASE3":2361,"PHASE4":2363,"NA":2365},{"trials":2352,"activeCount":99},[],{"trials":2354,"activeCount":99},[],{"trials":2356,"activeCount":99},[2357],{"nctId":1068,"briefTitle":1069,"status":646,"phases":2358,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":1073,"conditions":2359,"interventions":2360},[88],[1075],[1077,847,1078],{"trials":2362,"activeCount":99},[],{"trials":2364,"activeCount":99},[],{"trials":2366,"activeCount":99},[],{"intervention":1078,"totalTrials":115,"cells":2368},{"EARLY_PHASE1":2369,"PHASE1":2371,"PHASE2":2373,"PHASE3":2379,"PHASE4":2381,"NA":2383},{"trials":2370,"activeCount":99},[],{"trials":2372,"activeCount":99},[],{"trials":2374,"activeCount":99},[2375],{"nctId":1068,"briefTitle":1069,"status":646,"phases":2376,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":1073,"conditions":2377,"interventions":2378},[88],[1075],[1077,847,1078],{"trials":2380,"activeCount":99},[],{"trials":2382,"activeCount":99},[],{"trials":2384,"activeCount":99},[],{"intervention":2386,"totalTrials":115,"cells":2387},"Pregabalin 50mg",{"EARLY_PHASE1":2388,"PHASE1":2390,"PHASE2":2392,"PHASE3":2406,"PHASE4":2408,"NA":2410},{"trials":2389,"activeCount":99},[],{"trials":2391,"activeCount":99},[],{"trials":2393,"activeCount":99},[2394],{"nctId":2395,"briefTitle":2396,"status":451,"phases":2397,"primaryCompletion":2153,"completion":2398,"start":2399,"enrollment":2400,"conditions":2401,"interventions":2403},"NCT01333956","Effects of Pregabalin on Pain After Total Knee Arthroplasty",[87,88],"2013-06","2011-05",120,[2402],"Primary Total Knee Arthroplasty",[2386,2404,2405],"Pregabalin 100mg","Pregabalin 150mg",{"trials":2407,"activeCount":99},[],{"trials":2409,"activeCount":99},[],{"trials":2411,"activeCount":99},[],{"intervention":2404,"totalTrials":115,"cells":2413},{"EARLY_PHASE1":2414,"PHASE1":2416,"PHASE2":2418,"PHASE3":2424,"PHASE4":2426,"NA":2428},{"trials":2415,"activeCount":99},[],{"trials":2417,"activeCount":99},[],{"trials":2419,"activeCount":99},[2420],{"nctId":2395,"briefTitle":2396,"status":451,"phases":2421,"primaryCompletion":2153,"completion":2398,"start":2399,"enrollment":2400,"conditions":2422,"interventions":2423},[87,88],[2402],[2386,2404,2405],{"trials":2425,"activeCount":99},[],{"trials":2427,"activeCount":99},[],{"trials":2429,"activeCount":99},[],{"intervention":2405,"totalTrials":115,"cells":2431},{"EARLY_PHASE1":2432,"PHASE1":2434,"PHASE2":2436,"PHASE3":2442,"PHASE4":2444,"NA":2446},{"trials":2433,"activeCount":99},[],{"trials":2435,"activeCount":99},[],{"trials":2437,"activeCount":99},[2438],{"nctId":2395,"briefTitle":2396,"status":451,"phases":2439,"primaryCompletion":2153,"completion":2398,"start":2399,"enrollment":2400,"conditions":2440,"interventions":2441},[87,88],[2402],[2386,2404,2405],{"trials":2443,"activeCount":99},[],{"trials":2445,"activeCount":99},[],{"trials":2447,"activeCount":99},[],{"intervention":2449,"totalTrials":115,"cells":2450},"Abaloparatide 80 micrograms per Pen dose",{"EARLY_PHASE1":2451,"PHASE1":2453,"PHASE2":2455,"PHASE3":2467,"PHASE4":2469,"NA":2471},{"trials":2452,"activeCount":99},[],{"trials":2454,"activeCount":99},[],{"trials":2456,"activeCount":99},[2457],{"nctId":2458,"briefTitle":2459,"status":451,"phases":2460,"primaryCompletion":2461,"completion":2461,"start":2462,"enrollment":2463,"conditions":2464,"interventions":2466},"NCT04249232","Abaloparatide and Pelvic Fracture Healing",[88],"2024-04-25","2020-09-17",48,[2465],"Fracture of Pelvis (Disorder)",[2449],{"trials":2468,"activeCount":99},[],{"trials":2470,"activeCount":99},[],{"trials":2472,"activeCount":99},[],{"intervention":2474,"totalTrials":115,"cells":2475},"Atorvastatin",{"EARLY_PHASE1":2476,"PHASE1":2478,"PHASE2":2480,"PHASE3":2493,"PHASE4":2495,"NA":2497},{"trials":2477,"activeCount":99},[],{"trials":2479,"activeCount":99},[],{"trials":2481,"activeCount":99},[2482],{"nctId":2483,"briefTitle":2484,"status":451,"phases":2485,"primaryCompletion":2486,"completion":1213,"start":2487,"enrollment":670,"conditions":2488,"interventions":2492},"NCT02197065","Pilot Study of Atorvastatin for Orthopedic Surgery Patients",[88],"2016-07","2014-09",[2489,2490,2491],"Hip Fracture","Myocardial Ischemia","Inflammation",[2474],{"trials":2494,"activeCount":99},[],{"trials":2496,"activeCount":99},[],{"trials":2498,"activeCount":99},[],{"intervention":2500,"totalTrials":115,"cells":2501},"Teriparatide Prefilled Syringe",{"EARLY_PHASE1":2502,"PHASE1":2504,"PHASE2":2506,"PHASE3":2518,"PHASE4":2520,"NA":2522},{"trials":2503,"activeCount":99},[],{"trials":2505,"activeCount":99},[],{"trials":2507,"activeCount":99},[2508],{"nctId":2509,"briefTitle":2510,"status":451,"phases":2511,"primaryCompletion":2512,"completion":2513,"start":2514,"enrollment":711,"conditions":2515,"interventions":2517},"NCT02972424","PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial",[88],"2021-03-08","2021-07-08","2017-05-01",[2516],"Osteoporotic Fractures",[2500],{"trials":2519,"activeCount":99},[],{"trials":2521,"activeCount":99},[],{"trials":2523,"activeCount":99},[],{"intervention":673,"totalTrials":115,"cells":2525},{"EARLY_PHASE1":2526,"PHASE1":2528,"PHASE2":2530,"PHASE3":2536,"PHASE4":2538,"NA":2540},{"trials":2527,"activeCount":99},[],{"trials":2529,"activeCount":99},[],{"trials":2531,"activeCount":99},[2532],{"nctId":664,"briefTitle":665,"status":451,"phases":2533,"primaryCompletion":667,"completion":668,"start":669,"enrollment":670,"conditions":2534,"interventions":2535},[88],[636],[46,673],{"trials":2537,"activeCount":99},[],{"trials":2539,"activeCount":99},[],{"trials":2541,"activeCount":99},[],{"intervention":2543,"totalTrials":115,"cells":2544},"Somatropin",{"EARLY_PHASE1":2545,"PHASE1":2547,"PHASE2":2549,"PHASE3":2560,"PHASE4":2562,"NA":2564},{"trials":2546,"activeCount":99},[],{"trials":2548,"activeCount":99},[],{"trials":2550,"activeCount":99},[2551],{"nctId":2552,"briefTitle":2553,"status":1909,"phases":2554,"primaryCompletion":2555,"completion":2555,"start":2556,"enrollment":99,"conditions":2557,"interventions":2558},"NCT02597660","A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy",[88],"2020-12-01","2020-05-01",[1162],[2543,2559],"Bacteriostatic saline",{"trials":2561,"activeCount":99},[],{"trials":2563,"activeCount":99},[],{"trials":2565,"activeCount":99},[],{"intervention":2559,"totalTrials":115,"cells":2567},{"EARLY_PHASE1":2568,"PHASE1":2570,"PHASE2":2572,"PHASE3":2578,"PHASE4":2580,"NA":2582},{"trials":2569,"activeCount":99},[],{"trials":2571,"activeCount":99},[],{"trials":2573,"activeCount":99},[2574],{"nctId":2552,"briefTitle":2553,"status":1909,"phases":2575,"primaryCompletion":2555,"completion":2555,"start":2556,"enrollment":99,"conditions":2576,"interventions":2577},[88],[1162],[2543,2559],{"trials":2579,"activeCount":99},[],{"trials":2581,"activeCount":99},[],{"trials":2583,"activeCount":99},[],{"intervention":2585,"totalTrials":115,"cells":2586},"Nilotinib",{"EARLY_PHASE1":2587,"PHASE1":2589,"PHASE2":2591,"PHASE3":2602,"PHASE4":2604,"NA":2606},{"trials":2588,"activeCount":99},[],{"trials":2590,"activeCount":99},[],{"trials":2592,"activeCount":99},[2593],{"nctId":2594,"briefTitle":2595,"status":451,"phases":2596,"primaryCompletion":2597,"completion":2598,"start":2599,"enrollment":9,"conditions":2600,"interventions":2601},"NCT01166139","Nilotinib in the Treatment of Systemic Sclerosis",[88],"2014-07","2015-01","2010-07",[636],[2585],{"trials":2603,"activeCount":99},[],{"trials":2605,"activeCount":99},[],{"trials":2607,"activeCount":99},[],{"intervention":2609,"totalTrials":115,"cells":2610},"Tocilizumab",{"EARLY_PHASE1":2611,"PHASE1":2613,"PHASE2":2615,"PHASE3":2626,"PHASE4":2628,"NA":2630},{"trials":2612,"activeCount":99},[],{"trials":2614,"activeCount":99},[],{"trials":2616,"activeCount":99},[2617],{"nctId":2618,"briefTitle":2619,"status":451,"phases":2620,"primaryCompletion":649,"completion":2621,"start":2622,"enrollment":9,"conditions":2623,"interventions":2625},"NCT01396317","Study of Tocilizumab to Treat Polymyalgia Rheumatica",[88],"2016-01","2011-04",[2624],"Polymyalgia Rheumatica (PMR)",[2609],{"trials":2627,"activeCount":99},[],{"trials":2629,"activeCount":99},[],{"trials":2631,"activeCount":99},[],{"intervention":2633,"totalTrials":115,"cells":2634},"Imatinib Mesylate",{"EARLY_PHASE1":2635,"PHASE1":2637,"PHASE2":2639,"PHASE3":2649,"PHASE4":2651,"NA":2653},{"trials":2636,"activeCount":99},[],{"trials":2638,"activeCount":99},[],{"trials":2640,"activeCount":99},[2641],{"nctId":2642,"briefTitle":2643,"status":451,"phases":2644,"primaryCompletion":2645,"completion":2645,"start":2646,"enrollment":456,"conditions":2647,"interventions":2648},"NCT00555581","Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis",[88],"2011-12","2007-08",[636],[2633],{"trials":2650,"activeCount":99},[],{"trials":2652,"activeCount":99},[],{"trials":2654,"activeCount":99},[],{"intervention":2656,"totalTrials":115,"cells":2657},"Doxycycline Hyclate 20 MG",{"EARLY_PHASE1":2658,"PHASE1":2660,"PHASE2":2678,"PHASE3":2680,"PHASE4":2682,"NA":2684},{"trials":2659,"activeCount":99},[],{"trials":2661,"activeCount":99},[2662],{"nctId":2663,"briefTitle":2664,"status":451,"phases":2665,"primaryCompletion":2666,"completion":2666,"start":1814,"enrollment":2667,"conditions":2668,"interventions":2677},"NCT04686799","Doxycycline for Elbow Tendinopathy",[87],"2025-10-09",21,[2669,2670,2671,2672,2673,2674,2675,2676],"Lateral Epicondylitis","Lateral Epicondylitis, Left Elbow","Lateral Epicondylitis, Right Elbow","Lateral Epicondylitis, Unspecified Elbow","Lateral Epicondylitis (Tennis Elbow) Bilateral","Medial Epicondylitis","Medial Epicondylitis, Right Elbow","Medial Epicondylitis, Left Elbow",[2656],{"trials":2679,"activeCount":99},[],{"trials":2681,"activeCount":99},[],{"trials":2683,"activeCount":99},[],{"trials":2685,"activeCount":99},[],{"intervention":924,"totalTrials":115,"cells":2687},{"EARLY_PHASE1":2688,"PHASE1":2690,"PHASE2":2696,"PHASE3":2698,"PHASE4":2700,"NA":2702},{"trials":2689,"activeCount":99},[],{"trials":2691,"activeCount":99},[2692],{"nctId":917,"briefTitle":918,"status":451,"phases":2693,"primaryCompletion":478,"completion":920,"start":479,"enrollment":921,"conditions":2694,"interventions":2695},[87],[32],[845,924],{"trials":2697,"activeCount":99},[],{"trials":2699,"activeCount":99},[],{"trials":2701,"activeCount":99},[],{"trials":2703,"activeCount":99},[],{"intervention":2705,"totalTrials":615,"cells":2706},"Tranexamic Acid",{"EARLY_PHASE1":2707,"PHASE1":2709,"PHASE2":2711,"PHASE3":2713,"PHASE4":2715,"NA":2733},{"trials":2708,"activeCount":99},[],{"trials":2710,"activeCount":99},[],{"trials":2712,"activeCount":99},[],{"trials":2714,"activeCount":99},[],{"trials":2716,"activeCount":99},[2717,2727],{"nctId":2718,"briefTitle":2719,"status":451,"phases":2720,"primaryCompletion":2721,"completion":2721,"start":2722,"enrollment":2723,"conditions":2724,"interventions":2726},"NCT04089865","Oral Versus Intravenous Tranexamic Acid",[90],"2021-11-10","2019-09-17",400,[1337,2725],"Blood Transfusion",[2705],{"nctId":2728,"briefTitle":2729,"status":1909,"phases":2730,"primaryCompletion":993,"completion":994,"start":649,"enrollment":99,"conditions":2731,"interventions":2732},"NCT01940536","The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures",[90],[2489,1337],[2705],{"trials":2734,"activeCount":99},[2735],{"nctId":2736,"briefTitle":2737,"status":451,"phases":2738,"primaryCompletion":2739,"completion":2739,"start":2740,"enrollment":2741,"conditions":2742,"interventions":2744},"NCT02253810","Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy",[91],"2018-10","2014-10",89,[2743],"Dysplasia, Congenital Hip",[2705],{"intervention":2746,"totalTrials":95,"cells":2747},"Acetaminophen",{"EARLY_PHASE1":2748,"PHASE1":2750,"PHASE2":2752,"PHASE3":2754,"PHASE4":2756,"NA":2767},{"trials":2749,"activeCount":99},[],{"trials":2751,"activeCount":99},[],{"trials":2753,"activeCount":99},[],{"trials":2755,"activeCount":99},[],{"trials":2757,"activeCount":99},[2758],{"nctId":2759,"briefTitle":2760,"status":451,"phases":2761,"primaryCompletion":2762,"completion":2762,"start":2763,"enrollment":2764,"conditions":2765,"interventions":2766},"NCT03020966","IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty",[90],"2019-06-16","2017-02-16",154,[23,15],[2746,2746],{"trials":2768,"activeCount":99},[2769],{"nctId":2770,"briefTitle":2771,"status":451,"phases":2772,"primaryCompletion":2773,"completion":2774,"start":710,"enrollment":2775,"conditions":2776,"interventions":2780},"NCT02700451","Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes",[91],"2021-12-31","2023-03",178,[2777,2778,561,2779],"Lumbar Osteoarthritis","Spondylosis","Spinal Stenosis",[2781,2746],"Ketorolac",{"intervention":872,"totalTrials":95,"cells":2783},{"EARLY_PHASE1":2784,"PHASE1":2786,"PHASE2":2788,"PHASE3":2790,"PHASE4":2792,"NA":2798},{"trials":2785,"activeCount":99},[],{"trials":2787,"activeCount":99},[],{"trials":2789,"activeCount":99},[],{"trials":2791,"activeCount":99},[],{"trials":2793,"activeCount":99},[2794],{"nctId":860,"briefTitle":861,"status":451,"phases":2795,"primaryCompletion":863,"completion":863,"start":864,"enrollment":865,"conditions":2796,"interventions":2797},[90],[26],[808,868,869,870,871,872,873,845],{"trials":2799,"activeCount":99},[2800],{"nctId":2801,"briefTitle":2802,"status":451,"phases":2803,"primaryCompletion":1212,"completion":648,"start":2804,"enrollment":2805,"conditions":2806,"interventions":2808},"NCT02506673","Audiovisual Aid Pilot Study",[91],"2016-01-14",26,[2807],"Stress, Psychological",[872],{"intervention":2810,"totalTrials":115,"cells":2811},"Botulinum toxin type A",{"EARLY_PHASE1":2812,"PHASE1":2814,"PHASE2":2816,"PHASE3":2818,"PHASE4":2820,"NA":2822},{"trials":2813,"activeCount":99},[],{"trials":2815,"activeCount":99},[],{"trials":2817,"activeCount":99},[],{"trials":2819,"activeCount":99},[],{"trials":2821,"activeCount":99},[],{"trials":2823,"activeCount":99},[2824],{"nctId":2825,"briefTitle":2826,"status":451,"phases":2827,"primaryCompletion":2828,"completion":2828,"start":2829,"enrollment":2830,"conditions":2831,"interventions":2833},"NCT03112434","Muscle Elastography in Spastic Cerebral Palsy",[],"2020-12-30","2017-12-14",16,[2832],"Unilateral Spastic Cerebral Palsy",[2810],{"intervention":2835,"totalTrials":115,"cells":2836},"A. Control Nerve Block. IV Dexamethasone (4 mg).",{"EARLY_PHASE1":2837,"PHASE1":2839,"PHASE2":2841,"PHASE3":2843,"PHASE4":2845,"NA":2847},{"trials":2838,"activeCount":99},[],{"trials":2840,"activeCount":99},[],{"trials":2842,"activeCount":99},[],{"trials":2844,"activeCount":99},[],{"trials":2846,"activeCount":99},[],{"trials":2848,"activeCount":99},[2849],{"nctId":2850,"briefTitle":2851,"status":451,"phases":2852,"primaryCompletion":2645,"completion":2645,"start":2853,"enrollment":2854,"conditions":2855,"interventions":2857},"NCT01277159","Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine",[91],"2010-10",108,[2856],"Patients Undergoing Ankle Surgery",[2835,2858,2859,2860,2861],"B. Nerve Block with Dexamethasone (4 mg). IV saline.","C. Control Nerve Block. IV Dexamethasone","D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).","E. Nerve Block with Dexamethasone (4 mg) \u002F block Buprenorphine (0.3 mg).",{"intervention":2858,"totalTrials":115,"cells":2863},{"EARLY_PHASE1":2864,"PHASE1":2866,"PHASE2":2868,"PHASE3":2870,"PHASE4":2872,"NA":2874},{"trials":2865,"activeCount":99},[],{"trials":2867,"activeCount":99},[],{"trials":2869,"activeCount":99},[],{"trials":2871,"activeCount":99},[],{"trials":2873,"activeCount":99},[],{"trials":2875,"activeCount":99},[2876],{"nctId":2850,"briefTitle":2851,"status":451,"phases":2877,"primaryCompletion":2645,"completion":2645,"start":2853,"enrollment":2854,"conditions":2878,"interventions":2879},[91],[2856],[2835,2858,2859,2860,2861],{"intervention":2859,"totalTrials":115,"cells":2881},{"EARLY_PHASE1":2882,"PHASE1":2884,"PHASE2":2886,"PHASE3":2888,"PHASE4":2890,"NA":2892},{"trials":2883,"activeCount":99},[],{"trials":2885,"activeCount":99},[],{"trials":2887,"activeCount":99},[],{"trials":2889,"activeCount":99},[],{"trials":2891,"activeCount":99},[],{"trials":2893,"activeCount":99},[2894],{"nctId":2850,"briefTitle":2851,"status":451,"phases":2895,"primaryCompletion":2645,"completion":2645,"start":2853,"enrollment":2854,"conditions":2896,"interventions":2897},[91],[2856],[2835,2858,2859,2860,2861],{"intervention":2860,"totalTrials":115,"cells":2899},{"EARLY_PHASE1":2900,"PHASE1":2902,"PHASE2":2904,"PHASE3":2906,"PHASE4":2908,"NA":2910},{"trials":2901,"activeCount":99},[],{"trials":2903,"activeCount":99},[],{"trials":2905,"activeCount":99},[],{"trials":2907,"activeCount":99},[],{"trials":2909,"activeCount":99},[],{"trials":2911,"activeCount":99},[2912],{"nctId":2850,"briefTitle":2851,"status":451,"phases":2913,"primaryCompletion":2645,"completion":2645,"start":2853,"enrollment":2854,"conditions":2914,"interventions":2915},[91],[2856],[2835,2858,2859,2860,2861],{"intervention":2861,"totalTrials":115,"cells":2917},{"EARLY_PHASE1":2918,"PHASE1":2920,"PHASE2":2922,"PHASE3":2924,"PHASE4":2926,"NA":2928},{"trials":2919,"activeCount":99},[],{"trials":2921,"activeCount":99},[],{"trials":2923,"activeCount":99},[],{"trials":2925,"activeCount":99},[],{"trials":2927,"activeCount":99},[],{"trials":2929,"activeCount":99},[2930],{"nctId":2850,"briefTitle":2851,"status":451,"phases":2931,"primaryCompletion":2645,"completion":2645,"start":2853,"enrollment":2854,"conditions":2932,"interventions":2933},[91],[2856],[2835,2858,2859,2860,2861],{"intervention":483,"totalTrials":115,"cells":2935},{"EARLY_PHASE1":2936,"PHASE1":2938,"PHASE2":2940,"PHASE3":2942,"PHASE4":2944,"NA":2946},{"trials":2937,"activeCount":99},[],{"trials":2939,"activeCount":99},[],{"trials":2941,"activeCount":99},[],{"trials":2943,"activeCount":99},[],{"trials":2945,"activeCount":99},[],{"trials":2947,"activeCount":99},[2948],{"nctId":475,"briefTitle":476,"status":451,"phases":2949,"primaryCompletion":478,"completion":478,"start":479,"enrollment":285,"conditions":2950,"interventions":2951},[91],[481],[483,41],{"intervention":2953,"totalTrials":115,"cells":2954},"Low Dose",{"EARLY_PHASE1":2955,"PHASE1":2957,"PHASE2":2959,"PHASE3":2961,"PHASE4":2963,"NA":2965},{"trials":2956,"activeCount":99},[],{"trials":2958,"activeCount":99},[],{"trials":2960,"activeCount":99},[],{"trials":2962,"activeCount":99},[],{"trials":2964,"activeCount":99},[],{"trials":2966,"activeCount":99},[2967],{"nctId":2968,"briefTitle":2969,"status":451,"phases":2970,"primaryCompletion":2971,"completion":2971,"start":669,"enrollment":2764,"conditions":2972,"interventions":2974},"NCT01701115","Effect of Local Anesthetic Dose on Interscalene Block",[91],"2013-08",[893,2973],"Interscalene Block",[2953,2975],"Control Dose",{"intervention":2975,"totalTrials":115,"cells":2977},{"EARLY_PHASE1":2978,"PHASE1":2980,"PHASE2":2982,"PHASE3":2984,"PHASE4":2986,"NA":2988},{"trials":2979,"activeCount":99},[],{"trials":2981,"activeCount":99},[],{"trials":2983,"activeCount":99},[],{"trials":2985,"activeCount":99},[],{"trials":2987,"activeCount":99},[],{"trials":2989,"activeCount":99},[2990],{"nctId":2968,"briefTitle":2969,"status":451,"phases":2991,"primaryCompletion":2971,"completion":2971,"start":669,"enrollment":2764,"conditions":2992,"interventions":2993},[91],[893,2973],[2953,2975],{"intervention":2995,"totalTrials":115,"cells":2996},"BMA",{"EARLY_PHASE1":2997,"PHASE1":2999,"PHASE2":3001,"PHASE3":3003,"PHASE4":3005,"NA":3007},{"trials":2998,"activeCount":99},[],{"trials":3000,"activeCount":99},[],{"trials":3002,"activeCount":99},[],{"trials":3004,"activeCount":99},[],{"trials":3006,"activeCount":99},[],{"trials":3008,"activeCount":99},[3009],{"nctId":3010,"briefTitle":3011,"status":451,"phases":3012,"primaryCompletion":3013,"completion":3014,"start":3015,"enrollment":16,"conditions":3016,"interventions":3017},"NCT03130335","Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis",[91],"2019-08-12","2019-10-01","2017-04-28",[314],[2995],{"intervention":3019,"totalTrials":115,"cells":3020},"Pregabalin 150 mg",{"EARLY_PHASE1":3021,"PHASE1":3023,"PHASE2":3025,"PHASE3":3027,"PHASE4":3029,"NA":3031},{"trials":3022,"activeCount":99},[],{"trials":3024,"activeCount":99},[],{"trials":3026,"activeCount":99},[],{"trials":3028,"activeCount":99},[],{"trials":3030,"activeCount":99},[],{"trials":3032,"activeCount":99},[3033],{"nctId":3034,"briefTitle":3035,"status":451,"phases":3036,"primaryCompletion":1241,"completion":1241,"start":3037,"enrollment":950,"conditions":3038,"interventions":3040},"NCT01366196","Pregabalin for the Treatment of Pain After Posterior Spinal Fusions",[91],"2008-10",[3039],"Lumbar Spinal Fusions",[3019],{"intervention":2781,"totalTrials":115,"cells":3042},{"EARLY_PHASE1":3043,"PHASE1":3045,"PHASE2":3047,"PHASE3":3049,"PHASE4":3051,"NA":3053},{"trials":3044,"activeCount":99},[],{"trials":3046,"activeCount":99},[],{"trials":3048,"activeCount":99},[],{"trials":3050,"activeCount":99},[],{"trials":3052,"activeCount":99},[],{"trials":3054,"activeCount":99},[3055],{"nctId":2770,"briefTitle":2771,"status":451,"phases":3056,"primaryCompletion":2773,"completion":2774,"start":710,"enrollment":2775,"conditions":3057,"interventions":3058},[91],[2777,2778,561,2779],[2781,2746],{"intervention":3060,"totalTrials":115,"cells":3061},"Midodrine",{"EARLY_PHASE1":3062,"PHASE1":3064,"PHASE2":3066,"PHASE3":3068,"PHASE4":3070,"NA":3072},{"trials":3063,"activeCount":99},[],{"trials":3065,"activeCount":99},[],{"trials":3067,"activeCount":99},[],{"trials":3069,"activeCount":99},[],{"trials":3071,"activeCount":99},[],{"trials":3073,"activeCount":99},[3074],{"nctId":3075,"briefTitle":3076,"status":646,"phases":3077,"primaryCompletion":2598,"completion":2598,"start":3078,"enrollment":16,"conditions":3079,"interventions":3081},"NCT02154243","An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty",[91],"2014-06",[3080],"Orthostatic Hypotension",[3060],{"intervention":3083,"totalTrials":115,"cells":3084},"Melatonin",{"EARLY_PHASE1":3085,"PHASE1":3087,"PHASE2":3089,"PHASE3":3091,"PHASE4":3093,"NA":3095},{"trials":3086,"activeCount":99},[],{"trials":3088,"activeCount":99},[],{"trials":3090,"activeCount":99},[],{"trials":3092,"activeCount":99},[],{"trials":3094,"activeCount":99},[],{"trials":3096,"activeCount":99},[3097],{"nctId":3098,"briefTitle":3099,"status":451,"phases":3100,"primaryCompletion":2398,"completion":2398,"start":1241,"enrollment":800,"conditions":3101,"interventions":3105},"NCT01505465","Study of Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery",[91],[32,3102,3103,3104],"Delirium","Confusion","Sleep",[3083],{"intervention":3107,"totalTrials":115,"cells":3108},"Modafinil",{"EARLY_PHASE1":3109,"PHASE1":3111,"PHASE2":3113,"PHASE3":3115,"PHASE4":3117,"NA":3119},{"trials":3110,"activeCount":99},[],{"trials":3112,"activeCount":99},[],{"trials":3114,"activeCount":99},[],{"trials":3116,"activeCount":99},[],{"trials":3118,"activeCount":99},[],{"trials":3120,"activeCount":99},[3121],{"nctId":3122,"briefTitle":3123,"status":646,"phases":3124,"completion":3125,"start":3126,"enrollment":670,"conditions":3127,"interventions":3128},"NCT00297284","Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil",[91],"2007-02","2006-02",[765],[3107],{"intervention":3130,"totalTrials":115,"cells":3131},"Methylprednisolone Acetate",{"EARLY_PHASE1":3132,"PHASE1":3134,"PHASE2":3136,"PHASE3":3138,"PHASE4":3140,"NA":3142},{"trials":3133,"activeCount":99},[],{"trials":3135,"activeCount":99},[],{"trials":3137,"activeCount":99},[],{"trials":3139,"activeCount":99},[],{"trials":3141,"activeCount":99},[],{"trials":3143,"activeCount":99},[3144],{"nctId":3145,"briefTitle":3146,"status":451,"phases":3147,"primaryCompletion":3148,"completion":3149,"start":890,"enrollment":891,"conditions":3150,"interventions":3156},"NCT02539394","Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion",[91],"2020-11-12","2021-11-12",[3151,3152,3153,3154,3155],"Cervical Disc Herniation","Cervical Degenerative Disc Disease","Cervical Spondylotic Myelopathy","Dysphagia","Osteoarthritis of Cervical Spine",[3130]]